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ABSTRACT 
 
Micro/nano robots are considered a promising approach to conduct minimally invasive 
interventions. We have proposed to embed magnetic nanoparticles in therapeutic or diagnostic 
agents in order to magnetically control them. A modified clinical Magnetic Resonance Imaging 
(MRI) scanner is used to provide the driving force that allows these magnetically embedded 
microcarriers to navigate the vascular human network. By using specific Magnetic Resonance 
(MR) gradient sequences this method has been validated in previous research works. 
Magnetophoresis is the term used to describe the fact that a magnetic particle changes its 
trajectory under the influence of a magnetic force while being carried by a fluid flow. This 
movement depends on the particle’s magnetic characteristics, the particle’s geometric shape, the 
fluid flow’s attributes and other factors.  In our proposed method, magnetic microcarriers can be 
produced in several different ways, and so their response will differ to the same magnetic force 
and fluid flow conditions. The outcome of the therapeutic treatment using our method depends on 
the adequate selection of the therapeutic and/or diagnosis agents to be used. The selected 
therapeutic and/or diagnosis magnetic microcarrier also influences the selection of the MR 
gradient sequence that best fit for a given treatment. 
This master’s thesis presents the design of a device intended to assess the magnetophoretic 
properties of magnetic therapeutic microcarriers and/or diagnostic agents. Such characterization 
is essential for determining the optimal sequences of magnetic gradients to deflect their trajectory 
through relatively complex vascular networks in order to reach a pre-defined target. A 
microfluidic device was fabricated to validate the design. Magnetophoretic velocities are 
measured and a simple tracking method is proposed. The preliminary experimental results 
indicate that, despite some limitations, the proposed technique has the potential to be appropriate 
to characterize any drug and/or diagnosis magnetic microcarrier containing different magnetic 
nanoparticle content.  
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RÉSUMÉ 
 
Des micro/nano-robots sont considérés comme une approche prometteuse pour mener des 
interventions minimalement invasives. Nous avons proposé d'intégrer des nanoparticules 
magnétiques dans des agents thérapeutiques ou de diagnostic afin de les contrôler 
magnétiquement. Un scanner d’imagerie par résonance magnétique (IRM)  clinique modifié est 
utilisé afin de  fournir la force motrice qui permet à ces microporteurs magnétiques à naviguer 
dans le réseau vasculaire humain. En utilisant des séquences spécifiques des gradients de 
résonance magnétique (MR) cette méthode a été validée dans des travaux de recherche antérieurs. 
Magnétophorèse est le terme utilisé pour décrire le fait qu'une particule magnétique modifie sa 
trajectoire sous l'influence d'une force magnétique tout en étant portée par un flux de fluide. Ce 
mouvement dépend des caractéristiques de la particule magnétique, de sa forme géométrique, des 
attributs de l'écoulement de fluide et d'autres facteurs. Dans notre méthode proposée, les 
microporteurs magnétiques peuvent être réalisés de différentes manières, et donc leur réponse 
sera différente à la même force magnétique et dans les mêmes conditions d'écoulement de fluide. 
Le résultat du traitement thérapeutique utilisant notre méthode dépend de la sélection adéquate 
des agents thérapeutiques et/ou de diagnostic à utiliser. Le microporteur magnétique 
thérapeutique et /ou de diagnostic choisi influe également sur le choix de la séquence des 
gradients magnétiques que meilleur se ajustement pour un traitement donné. 
Ce mémoire de maîtrise présente la conception d'un dispositif destiné à évaluer les propriétés 
magnétophorétiques des agents microporteurs magnétiques thérapeutiques et/ou de diagnostic. 
Une telle caractérisation est essentielle pour déterminer les séquences optimales des gradients 
magnétiques pour dévier leur trajectoire à travers des réseaux vasculaires relativement complexes 
dans le but d'atteindre un objectif prédéfini. Un dispositif microfluidique est fabriqué pour valider 
la conception. Las vitesses magnétophorétiques sont mesurées et une méthode de suivi simple est 
proposée. Les résultats des experiences préliminaires indiquent que, malgré certaines limitations, 
la technique proposée a le potentiel d’être approprié pour caractériser n'importe quel 
microporteur magnétique thérapeutique et/ou de diagnostic contenant différents taux de 
nanoparticules magnétiques. 
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CHAPTER 1 INTRODUCTION 
 
1.1 Background and motivation 
Minimally invasive interventions are attracting a lot of interest in the research community, 
mainly due to the advantages of this kind of interventions: reduced patient recovery time, shorter 
stay in the hospital and fewer complications. In the context of the Magnetic Resonance 
Submarine (MR-Sub) project a new minimally invasive technique for cancer treatment and 
diagnosis, called Magnetic Resonance Navigation (MRN), has been proposed. This technique is 
based on the use of the main magnetic homogeneous field and the magnetic gradients of an 
upgraded Magnetic Resonance Imaging (MRI) scanner in order to navigate therapeutic or 
diagnostic agents with embedded magnetic nanoparticles to target specific locations in the 
vascular human network. 
Most of current cancer treatments involving drug administration are systemic, which means 
that the drugs are delivered in the bloodstream causing them to affect cells all over the organism 
with just around 1% or less destroying tumor cells [1, 2]. The MRN technique is expected to 
produce a significant increase in targeting efficiency and the feasibility of this method has 
already been demonstrated [3] by our research group. 
A major challenge faced in this technique is the fact that the human vasculature is very 
complex and heterogeneous with vessels ranging from some millimeters (major arteries) to a few 
micrometers (arterioles, capillaries) in diameter. To accommodate the smaller human body 
vessels, the drug carrier size must be reduced, which in turn reduces the amount of drug that can 
be transported. On the other hand, smaller carriers are more difficult to be navigated due to its 
reduced magnetic volume. 
In [4, 5] it was demonstrated that it is possible to produce a drug carrier of about 50 µm in 
diameter size to target a tumor deep inside the body. However, in [6] the authors noticed that 
normal MRI gradient coils were not sufficient to allow steering of magnetic microcarriers in a Y-
shaped bifurcation, then upgraded gradient coils were tested and validated. In this last study it 
was also stated that, in order to improve steering efficiency, it could be exploited the fact that 
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magnetic microcarriers tend to agglomerate when being used as therapeutic and/or diagnosis 
vectors. 
For improving targeting efficiency by using the aggregation of magnetic microcarriers we 
are obligated to understand and evaluate the response of these aggregations when subjected to 
magnetic gradients. In different given conditions of fluid flow and magnetic force, magnetic 
microparticle aggregations show different deflection patterns. Thus the study of this deflection 
patterns gives clues on the magnetic response of them. Hence, by evaluating deflection patterns 
the magnetophoretic velocity of these entities can be estimated and used to predict their behavior 
in treatment conditions. 
Moreover, in [7] it has been published that even for magnetic microspheres of the same size 
prepared under the same conditions, magnetophoretic velocities can differ by a factor of 4 or 
more. This emphasizes the need for an instrument to estimate magnetic microcarriers response to 
magnetic gradients when designed to be used in targeted drug delivery and/or diagnosis 
applications in the context of MRN treatments.  
1.2 Problem statement 
The main goal of the MR-Sub project is to develop a platform capable of navigating 
magnetic microcarriers in the human cardiovascular system according to a pre-defined pathway.  
1.2.1 Thesis objectives 
The objective of this thesis is to design a device in order to collect data on the magnetic 
response of the microcarriers when used in MRN. To attain this objective the main goal is 
divided in the following sub-goals: 
• design a microfluidic chamber in order to allow the magnetic microcarriers to move 
while following the fluid flow,  
• record microparticles’ course when subjected to a magnetic steering force 
perpendicular to the direction of the flow.  
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• estimate the magnetophoretic velocity of magnetic particles, that in turn, should 
allow estimating the trajectory that a microcarrier would follow under similar 
circumstances. 
Main contributions of the work for this thesis are:  
• a conference paper presented in the 3M-NANO 2012 Conference (International 
Conference on Manipulation, Manufacturing and Measurement on the Nanoscale) in 
Xi’an, China under the title: “Characterization by magnetophoresis of therapeutic 
microcarriers relying on embedded nanoparticles to allow navigation in the vascular 
network” [70]; this work was selected as a Best Conference Paper Award Finalist.   
• a journal paper published in 2013 in the Journal of Micro-Bio Robotics as: G. Vidal 
and S. Martel, "Measuring the magnetophoretic characteristics of magnetic agents 
for targeted diagnostic or therapeutic interventions in the vascular network" [10] .  
• a microfluidics chamber design for magnetophoretic experiences. 
• a basic software tracking tool tailored for the conditions of the magnetophoretic 
experiences performed. 
Unless the contrary is indicated, the developments presented in this document are the 
contribution of the author. Exceptions are indicated and mainly are: OpenCV blobtrack modified 
application that was adapted by Behnam Izadi for experiences in Ke Peng’s master thesis work 
[8] and Joerg Buchholz’s Particle System Toolbox [9] used for magnetic microparticles 
movement simulations. 
1.3 Overview of the thesis 
The thesis organization is as follows: in the first chapter the background, motivation and 
problem statement are presented; in Chapter 2 there is a literature review on the way in which the 
trajectory of magnetic particles has been studied before and its previous applications; in Chapter 
3 the approach used in this work is presented; in Chapter 4 the published paper [10] showing the 
preliminary results of the selected design in its original version is introduced; Chapter 5 
introduces the proposed tracking method based on finding presented in Chapter 4; Chapter 6 
4 
 
presents a general discussion of this work; finally Chapter 7 summarizes the project and presents 
future perspectives for it.  
5 
CHAPTER 2 LITERATURE REVIEW 
 
Retrieving data on the reactivity shown by MR navigable microcarriers seems to be 
fundamental in order to determine optimal control sequences during MRN treatments. This 
chapter focuses on providing an overview of previous work on the techniques for observing 
magnetic microparticles' trajectories, on the importance of aggregations in the context of MRN 
and the need for a method to estimate compared drug/diagnosis magnetic microcarriers 
performance. On the basis of this review the main advances in the area are highlighted. 
2.1 Magnetophoresis 
The study of the movement of magnetic particles in a fluid induced by the influence of a 
magnetic field (termed as magnetophoresis) has been the object of research in several works. As 
early as in 1960, an apparatus was proposed to measure the magnetic susceptibility of single 
particles by determining the velocity that particles get when in an inhomogeneous magnetic field 
[11]. This apparatus used a microscope to observe a particle’s trajectory and a stop watch to time 
the movement and then estimate the particle’s assumed velocity. 
2.1.1 Magnetism basic concepts 
In order to understand magnetophoresis, some basic definitions on magnetism in materials 
are required.  
The magnetic induction, B1, is the response of a given material to an applied magnetic 
field, H. The relationship between B and H is given by (in SI units): 
  = 	 μ(		 + 	) 2-1 
                                                 
1
 In this document bold letters indicate vectors : for example A is a vector and A is a scalar indicating the magnitude 
of vector A. 
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where µ0 is the  permeability in free space and M is the magnetization induced inside the material 
and is dependent on the characteristics of it. The magnetization is defined as the magnetic 
moment per unit volume 
 
 =


 
2-2 
where m is the dipole magnetic moment and V  is the volume of the magnetic material. The 
magnetic moment relates to the torque that is exerted on a magnet dipole or a current loop when a 
magnetic field is applied. The dipole magnetic moment of a material depends mainly on orbital 
and spin magnetic moments of the electrons in the constituent atoms of it.  
The magnetic susceptibility of a material is defined by 
 =  

	
                                                          2-3 
The susceptibility is an indication of the responsiveness of a material to an applied magnetic 
field. Magnetization curves are built by plotting M versus H (or B versus H), and are used to 
identify the magnetic type of material. 
The magnetic permeability is defined by 
μ =

	
                                                                     2-4 
and indicates how permeable a material is to the applied magnetic field. 
Permeability µ and susceptibility χ (in SI units) are related by 
μ =  μ(1 +  )                                                         2-5 
with µ0 the permeability in free space. 
Materials are classified as diamagnetic, paramagnetic, antiferromagnetic, ferrimagnetic and 
ferromagnetic depending on their magnetic characteristics. For diamagnetic, paramagnetic and 
antiferromagnetic materials, magnetization curves are linear; a relatively large applied field is 
required to produce changes in magnetization and there is no remanent magnetization if the 
applied field is removed. For ferrimagnetic and ferromagnetic materials, magnetization curves 
have the typical hysteresis loop form; there is a magnetization saturation point after which 
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negligible change is produced in magnetization by increasing the applied field and removing the 
applied field does not reduce magnetization to zero (if saturation has been reached), this remanent 
magnetization has several technological applications [12]. 
2.1.2 Magnetic force 
When an inhomogeneous magnetic field is applied to a particle, this magnetic field exerts a 
force on the particle given by: 
 = ( ∙ )                                                          2-6 
where m is the dipole magnetic moment and ∇B is the external magnetic field gradient. By using 
Eq. 2-2, we obtain the usual magnetic force expression used in this work: 
 =  	( ∙ )                                                     2-7 
where Vf  is the volume of the magnetic content [13]. 
On the other hand, in order to obtain magnetic susceptibility data from magnetophoretic 
experiments, it is usual to assume that the magnetic induction B and the magnetic applied field H 
are just related by permeability in free space, neglecting the effect of the magnetization M: 
 =	μ	                                                              2-8 
By combining Eq. 2-3 and Eq. 2-8 we obtain: 
 = μ0                                                              2-9 
Then Eq. 2-7 becomes: 
 =  	 μ0 ( ∙ )                                       2-10 
Additionally as the moving particle displaces a fluid volume, it is also usual to take into account 
the magnetic force exerted on the medium, which leads to: 
 = − 	

μ0
( ∙ )                                    2-11 
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with χm the susceptibility of the fluid medium, and the minus sign indicates that this force is 
opposed to Fmag. Then, the usual expression for the net force on a magnetic particle exerted by a 
magnetic inhomogeneous field is expressed in terms of the difference in susceptibility between 
the particle and the fluid: 
 =  	μ0 ( ∙ )                                              2-12 
with ∆χ = χ - χm. 
Finally, by applying a mathematical identity2 and the fact that there are no electric currents 
involved in the discussed setup, we obtain: 
 	= 	(
2
2μ0
)                                               2-13 
which is the other usual form encountered in articles related to magnetophoresis [13, 14, 15]. It is 
commonly supposed that the inhomogeneous magnetic field varies only in one of the coordinate 
axes, then the magnitude of the force can be written as: 
 !"#$ 	= 	%( &
2
2μ0
)                                               2-14 
where the operator ∇ is the standard derivative in the selected direction and B is the magnitude of 
the magnetic field in that direction. 
2.1.3 Microfluidics basics 
A microfluidics is a device that deals with fluid flow in channels with at least one 
dimension between 1 mm to 1 µm. When at least one of the dimensions of the channel is less 
than 1 µm, it is called nanofluidics. 
Among the main advantages of microfluidics are: small sample quantities needed, high 
portability, fast and reliable results, and easy fluid control is possible. 
                                                 
2
 ( ∙ ) = 2 × ( × ) + 2( ∙ ), as there are no electric currents ∇×B = 0 
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Fluid flows are characterized by the Reynolds number, a dimensionless parameter defined 
as: 
'(	 = 	)*+,-.	/                                                           2-15 
where Uflow is the average velocity of the flow, L is the characteristic or most relevant length 
scale and ν is the kinematic viscosity of the fluid (defined as the dynamic viscosity µ divided by 
the density of the fluid ρ). This parameter describes the ratio between inertial and viscous forces 
in a fluid. The characteristic length L in channels is the hydraulic diameter Dh defined by:  
12 	= 445 	                                                            2-16 
with A the channel’s cross-sectional area and P the channel’s wetted perimeter. 
Dimensions in microfluidics are small, which means that the Reynolds number is usually 
low, typically much less than 2100. This means that in microfluidics the flow regime is 
commonly considered as laminar flow. In this case, most flow patterns are simple, and are even 
expected to closely follow the geometry of the microfluidic channel [16]. 
When a rigid sphere moves in a microchannel and the Reynolds number for it is very low, 
the Stokes drag force formula is used: 
67 	=	−69:;<                                         2-17 
where r is the radius of the sphere, µ is the viscosity of the fluid and U is the microparticle’s 
velocity. 
By using Eq. 2-16 and Eq. 2-12 (or Eq. 2-13), and considering steady-state (no 
acceleration, i.e., drag and magnetic forces balance) it is possible to obtain an estimate of the 
magnetic susceptibility of magnetic microparticles by measuring their magnetophoretic velocity. 
2.1.4 Magnetophoretic trajectory observation 
Video imaging based analysis of particles trajectory was proposed in [17] to determine the 
magnetic susceptibility of large numbers of individual particles. This study utilized particle 
tracking velocimetry (PTV) on videotaped sequences. PTV is a technique intended to analyze 
complex fluid fields by tracking individual seeds circulating with the fluid. This technique was 
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first proposed with this name in [18]. In [19] the PTV’s most recent algorithm version at the time 
is used. As PTV function is to visualize the fluid, particles are not individualized through the 
sequence of frames, which is a drawback in the proposed technique. 
 In [19, 20, 21] an instrument named as cell tracking velocimetry (CTV) was proposed for 
allowing the determination of the velocity of labeled cells and paramagnetic particles 
simultaneously by using microscopic video imaging and a computer algorithm, in a well-
characterized magnetic energy gradient. The CTV had the objective of providing better insights 
for the outcomes to be expected in the magnetic cell separation process. The CTV is based on 
PTV, mainly solving the problem of particle’s identification through video frames. CTV has been 
also used to investigate magnetophoretic mobility changes produced in human blood cells by 
some infections [22].  
In the context of drug delivery mediated by the use of treatment vectors with embedded 
magnetic particles, an optical method to measure the magnetic response, in some way a 
simplified CTV setup, is proposed in [23]. The main differences with the CTV technique are a 
reduced setup size, and the use of a commercial program for particle tracking and video 
acquisition (CTV used videotaped sequences). 
Recently a method called magnetophoretic trajectory tracking magnetometry (MTTM) has 
been presented [24] with the aim of measuring a quantity defined as relative specific magnetic 
susceptibility by fitting the particle's observed trajectories with theoretical curves. The main 
difference of this method with CTV is the fact that particle's recorded trajectories are long 
compared with particle size. 
All techniques presented hitherto study magnetic particles or cells in a still fluid. A 
technique referred as magnetophoretic velocimetry was proposed in [25, 26, 27, 28] to determine 
paramagnetic species adsorbed by single droplets through the analysis of the acquired 
magnetophoretic velocity under a high gradient magnetic field. The magnetic susceptibility of the 
droplets was expected to change according to the adsorption and be reflected by a change in their 
magnetophoretic velocity. In this technique the capillary contains a fluid that is moving and the 
migration of species is observed as a deviation from the fluid flow acquired speed. 
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Magnetophoretic velocity measurements were also exploited to evaluate the particle uptake 
in magnetic labeling of cells [29, 30, 31]; in [7] the measured magnetophoretic velocity of 
magnetically coated microspheres roughly scaled with the surface area. 
2.2 Magnetic Manipulation 
Basic magnetic manipulation of particles in microfluidics is classified, according to Gijs 
[32], in: 
• Retention and separation: usually magnetic particles are immobilized by using a magnet, 
the magnetic material is separated from the solution in this way and can be analyzed a 
posteriori. Several other alternatives exist, for example continuous flow separation by 
Pamme’s group [39]. 
• Magnetic transport: In this approach, instead of deflecting the particles’ trajectory while 
moving with flow, magnetic particles move because of the action of magnetic actuation. 
This kind of manipulation is difficult due to the particles’ usual reduced magnetic volume. 
• Magnetic labeling for detection: In this case, a magnetic label is attached to an entity of 
interest, and then detection devices are used to measure the produced magnetic field. 
• Bead-flow interaction and mixing: magnetic particles tend to form chain-like aggregates 
due to dipole-dipole interactions. These aggregates can be used as plugs in certain 
applications, and by dynamically manipulating magnetic aggregations fluid mixing is 
possible in others. 
One possible application of magnetophoresis is magnetic manipulation of magnetic 
particles as in separation, sorting and capture [15, 33]. For example, high gradient magnetic 
separation (HGMS) systems are used [34, 35, 36] to remove magnetic particles from a fluid flow. 
HGMS consists basically of a matrix of ferromagnetic material (wires or filaments) that captures 
magnetic particles as fluid flow passes through it while a high magnetic field is applied. After 
filtration has finished, the magnetic material is washed out as the magnetic field is turned off. The 
advantage of HGMS, to previous techniques of magnetic separation, is that allowed the trapping 
of relatively weak magnetic particles, which makes it suitable for biological applications [15]. 
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As described in [37, 38], the relationship between magnetic manipulation and microfluidics 
is relatively recent. Pamme's group has developed a technique called free-flow magnetophoresis, 
a form of continuous flow separation that uses magnetic force to deflect the entities of interest 
[39, 40, 41, 42]. In this technique, magnetic particles are decoupled and deviated from their initial 
movement in a specific region of a magnetophoretic chamber. By these means, magnetic labeled 
particles exit the chip at specific positions depending on their magnetic properties. These outputs, 
with magnetic particles separated and sorted, can be used as inputs for other stages in more 
complex microfluidics applications. It is a continuous flow technique because magnetic particles 
are not trapped at certain regions of the microfluidics as in most other retention-separation 
methods. On the other hand, Furlani’s group has focused in developing models for predicting 
magnetic separation in different microfluidics systems and applications [43, 44, 45, 46].  
In [47] a microfluidic device was designed for magnetic bead immunoassays. The main 
focus in this work is to automate as much as possible the assay by incubating the microparticles 
in the reagent while in continuous flow. The microparticles are moved from sample flow to 
reagent flow by using a magnetic translational force. 
Examples as the above ones show the potential use of the magnetophoresis jointly with 
microfluidics to manipulate magnetic or magnetically functionalized particles.  
2.3 Magnetic Resonance Navigation 
The concept of MRN (Magnetic Resonance Navigation) is defined in [48] and it can be 
summarized as a method in which magnetically loaded therapeutic/diagnosis microcarriers are 
propelled and navigated by using gradient magnetic fields while inside the bore of an MRI 
scanner. In the first attempts to use MRN, the gradient magnetic forces were produced by the 
standard imaging coils of a MRI scanner. Since these initial experiences with MRN using 
millimetric sized cores as proof of concept [3, 49, 50], it was clear that magnetic propulsion 
forces produced by imaging coils of a standard MRI scanner were not suitable to navigate 
micro/nano sized carriers. In [51] it was shown that to perform navigation of micron sized agents 
in the form of a suspension, the use of enhanced magnetic gradient coils is needed and it was 
clear that the magnetic aggregation between particles due to dipole-dipole interaction could 
influence targeting efficiency. In [6, 52] aggregations were studied more deeply and it was 
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suggested that, due to its increased magnetic volume, they could be used to compensate the 
reduction of the propulsion force acting on individual magnetic particles. 
The potential use of magnetic aggregation to improve therapeutic effectiveness has been 
pondered by research groups that intend to use MRN for other applications. The use of MRN for 
lung treatment by using aerosol drug delivery was explored in [53]; they conclude that the use of 
magnetic agglomerations is needed in order to allow the navigation of magnetic loaded aerosol 
drugs in the lungs. The size of the agents used in lung treatment means that enhanced gradient 
coils, as those proposed in [51], are not able to generate the forces needed to steer the magnetic 
agents. Then, the only way to overcome this problem is by exploiting magnetic agglomerations. 
In other studies, they proposed a detailed mathematical model [54, 55] for the forces involved in 
the magnetic aggregation process. The expected advantage of this theoretical framework is the 
possibility for assessing the steering efficiency without the need of performing actual 
experiments. They compared simulation results with the experiences performed in [6], and they 
argued that the simulation framework agreed with experiences. However they get 100% 
efficiency in the same situation as the experiences, but in the experimental setup it was not 
observed. On the other hand due to the non-slip boundary condition, they expected 0% efficiency 
when needle-like aggregations were parallel to the main flow, which seems unlikely. 
Another possible application for MRN is the cell transplantation therapy. In [56] it was 
shown that MRN could be suitable for cell transplantation therapies, and in [57] the effect of 
magnetic cell aggregation was studied as an important factor to increase targeting efficiency. The 
improvement in targeting efficiency was attributed to the fact that cell aggregations show a 
higher magnetophoretic velocity. 
In the context of MRN, all the presented works concluded that the steering ratio could be 
enhanced by exploiting magnetic aggregation. On the other hand, therapeutic agents are expected 
to be synthesized in several ways depending on their expected usage. For example, some could 
contain higher quantities of embedded magnetic nanoparticles while other could contain more 
therapeutic drug. This diversity is expected to play a role also in the therapeutic agents’ response 
to the exerted magnetic force produced by the gradient coils. For example, in [7] it was found that 
magnetic microspheres of the same size, prepared under similar conditions, presented 
magnetophoretic velocities differing by up to a factor of 4. Each one of the different therapeutic 
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agents could produce magnetic aggregations differing in size, stiffness, geometry, etc., and, 
therefore, behave differently in similar flow conditions and under the influence of the same 
magnetic gradient field. Moreover, in real treatment circumstances, physiological parameters 
could change unexpectedly. Additionally, in MRN fluid flow velocities are the ones found in 
human vascularity, which are relatively high when compared with fluid flow in experimental 
conditions in other applications.  
To the best of our knowledge, there have been no other attempts to experimentally measure 
the trajectory of magnetic microcarriers in the context of MRN. In CTV and similar studies, there 
was no fluid flow involved; vertical and horizontal movements are due to gravity and magnetic 
force, respectively. The magnetic gradient was usually produced by a magnetic dipole, while in 
MRN it is produced by enhanced magnetic gradient coils. Finally, in our experimental conditions 
the magnetic micro-entities are inside the bore of a MRI scanner, therefore they are magnetized 
by the MRI’s magnetic homogeneous field, and there are dipole-dipole interactions between 
them. All of these conditions justify the design of a magnetophoretic testbench to study the 
trajectories of magnetic microcarriers to be used for MRN treatments in order to quantify their 
response to a given magnetic gradient in terms of their deflection patterns. 
2.4 Object tracking  
Observation of magnetic microcarriers’ trajectory means that software for their detection 
and tracking is needed. Object tracking has been the subject of a large amount of studies in 
computer vision and image processing [58] and has applications in many different areas as 
biology [59] and video surveillance [60]. The tracking problem can be defined as the survey of 
the movement that an object (or objects) follows in a sequence of frames of a video. 
 The first question to answer in this kind of application is to define the object to track. The 
answer to this question constitutes the way in which the object of interest is to be detected and 
represented. According to [58], the main object detection mechanisms are point detectors, 
background subtraction, segmentation, and supervised learning. In point detectors the aim is to 
find points in the object that are invariant to changes in illumination and camera viewpoint. 
Background subtraction uses a model for the static background and moving objects are frame 
regions that differ from this stationary background model (pixels that deviate from the 
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background model are marked for processing and are labeled as foreground pixels). Segmentation 
divides the image in partitions with similar characteristics. Finally, in supervised learning a 
training set is used to provide a model of the object to be detected. Once the object has been 
detected there are many ways of representing it, for example using geometric shapes, contours, 
points, etc. Usually this depends on the characteristics of the object being tracked. For example, 
for using in confocal microscopy, recently a new method for particle detection has been presented 
in [61] by exploiting radial symmetry of particles about its center. Particles' centers are located 
and represented as points. The algorithm determines the point of maximal radial symmetry by 
calculating the intensity gradient that it is expected to point towards the origins (particles’ 
centers). 
The next step in object tracking is to define the way in which the features selected 
representing the object are going to be located in the next frame given its position in the previous 
one. In this case, a displacement model is needed in order to define a search area. Some popular 
models used are deterministic translational model [62] and Kalman filter method that uses the 
state space approach. It is intended to deal with noise and random perturbations that usually occur 
in real video data [58]. 
Finally, once the search area has been determined, it is needed to locate the object in it and 
a matching criterion is needed. One of the most common matching criteria is template matching 
in which a representative instance (template) of the object is defined in previous frames, then this 
template is compared within defined search regions in the current frame by evaluating similarity 
functions. This approach is usually a brute force method, exhaustive in nature. Another common 
matching criterion is the brightness constancy used in optical flow that is based in the assumption 
that corresponding pixels in consecutive frames have no brightness change [58]. 
As pointed out in [59], it seems that automatic tracking results are still rarely perfect and 
experimental conditions usually produce problems to tracking tools in most of the cases, due to 
the fact that these applications are usually tightly linked to their specific application. 
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2.4.1 Particle Tracking 
Object tracking applied to motion of particles uses several specific approaches and the 
literature on the subject is extensive. Only some algorithms used in particle tracking that are of 
interest for this project are presented here. 
Micro Particle Image Velocimetry (µPIV): this technique is an adaptation of the Particle Image 
Velocimetry (PIV) technique for use in microfluidics. It was introduced by Santiago et al [63]. 
PIV techniques are intended to measure instantaneous fluid velocities. Usually fluorescent 
particles are seeded into the fluid flow and the particles’ displacement is evaluated by image 
treatment techniques. 
The typical PIV algorithm uses correlation to evaluate particles’ displacement. Frames are 
divided into areas; these areas are called interrogation areas or windows. Mathematical 
correlation calculation gives a measurement of similarity between interrogation windows. The 
Fast Fourier Transform (FFT) is often used to obtain the correlation, then the peak location is 
estimated and the displacement is derived. 
Correlation is usually calculated by using cross-correlation, but auto-correlation has also 
been used. In auto-correlation one frame contains a double exposure recording. The drawback 
with auto-correlation is that flow direction must be known prior to apply it, because it results in 
more than one correlation peaks (typically three). In cross-correlation method, each exposure 
corresponds to an individual frame, the correlation calculation results in a single correlation peak 
that contains velocity information [64]. 
Particle Tracking Velocimetry (PTV): the aim of this method is mainly the one of the PIV. The 
main difference is that in this technique few particles are tracked, compared with high particle 
densities used in PIV. In fact, is often called low-image-density PIV. 
In PTV, seeded particles are identified and tracked in the frame sequence. As mentioned 
before, one of the first introductions of PTV is done in [18]. A typical PTV algorithm consists of 
two main steps: particle identification to locate particles in a given frame and matching algorithm 
to evaluate the position of the identified particle at different times.  Most of the research effort for 
this method has focused on improving the matching feature algorithm used to track particles in 
frame sequences.  
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Some of the best known PTV matching methods are: nearest-neighbor search with 
geometrical constraints, cross correlation between two frames, relaxation methods that analyze 
the probability of particle matching and genetic algorithms [65]. 
Computer vision designed techniques have been adapted for PTV. For example, Ruhnau et 
al. [65] use optical flow to track particles, and recently in [66] a computer vision based approach 
has been proposed to deal with particles’ overlapping problem in frame sequences. 
Cell Tracking Velocimetry (CTV): this technique is a modified version of the PTV method used 
and developed in the Ohio State University [19]. This technique uses an image enhancement step 
prior to identification and tracking stages. The image enhancement steps are: histogramming used 
to find the range of the gray level present in the image, stretching used to improve contrast 
between particles and background, low-pass spatial filtering to remove noise, background 
subtraction and a final filtering step based on patterns to reconstruct incomplete cell images. 
After image enhancement, the cell tracking algorithm is applied. This algorithm has two 
steps. The first step is cell location, which is based on a threshold level comparison to deduce if a 
given pixel is part of a particle (higher intensity than the threshold) or not. Once particles are 
located, a tracking module is used to establish the most probable path by using a sequence of five 
frames. The concept of path coherence is used to determine the particles’ paths. This concept 
supposes that object trajectory should be smooth. In Figure 2-1 the method is shown; cells 
positions for each of the five consecutive frames are t1, t2, t3, t4 and t5. Using the cell position in 
the first frame (t1) as center, a search area is determined by radius “r” in the second frame. The 
determination of this radius depends on several considerations, usually ranges between 1 to 3 
times the cell diameter. Once the position in the second frame (t2) is established, the direction of 
movement and distance between them can be established (red line). From this information the 
location of the cell in the next frame is predicted (cell tagged as “p” near to t3 in this example). 
The error between real and predicted locations is used in a penalty function used to determine 
path coherence; the smaller the value of the penalty function, the greater the path coherence. The 
penalty function is used when more than one cell is identified in the search area of the next 
frame; the path with the smallest penalty function value is selected as the correct path. The 
procedure is repeated for frames 4 and 5. Finally the process is reversed, that is, the analysis is 
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done starting with frame 5 and ending with frame 1. If penalty function values have large 
differences in forward and reverse directions, then the paths are defined as not reliable [67]. 
 
Figure 2-1 CTV method schematics. Cells identified in the five consecutive 
frames are named t1 to t5 respectively. The search area between frames is 
determined by radius r. A predicted location of the cell in frame 3 is indicated as 
p. The real cell path is depicted in green. 
 
A multiple-frame PTV approach has been recently presented [68]. The main modification 
focuses in the way in which the prediction of particle position and velocity estimate is used to 
determine the radius of the search area in the next frame. It is expected that this method would 
improve the robustness and accuracy of PTV for highly seeded flows. 
To summarize, to our best knowledge, the techniques to track moving particles have been 
adapted from methods used to study fluid flow behavior. PIV technique is commonly intended to 
provide information on the average fluid flow velocity, and PTV technique identifies and tracks 
individual particles. Given a specific problem, particle tracking approaches have been developed 
tailored to the specificities of the experimental conditions.     
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The aim of this thesis is to design a testbench device to characterize the microcarriers to be 
used as therapeutic/diagnosis carriers in order to better predict targeting efficiency in MRN 
treatments. The general goal of the MR-Sub project is to develop a navigation method for 
medical microcarriers to target deep regions in the human body by using an upgraded MRI 
system. This method has been demonstrated in vitro and in vivo [3, 4, 51]. 
In his Ph.D. thesis, J.B. Mathieu investigated the methods for navigating several 
microparticles as carriers for cancer treatment [69], concluding that magnetic aggregation of 
microparticles modifies their response significantly, but they were not completely characterized. 
The current work tries to build an incremental step in this subject by following some of the 
suggestions in J.B. Mathieu’s work, focusing on the study of the deflection trajectories, i.e., 
magnetophoretic velocities of aggregations to allow a better treatment prediction. 
In order to do so, first of all it was needed to develop a microfluidic device allowing 
measurements of magnetophoretic response of magnetic particles and aggregations. As exposed 
in the literature review, magnetophoresis has been used for sorting and separation purposes, then 
a microfluidic chamber inspired in these applications was designed and tested to record 
microparticle aggregation movements. This design was presented as a conference paper in [70]. 
This work is a proof of concept of the magnetophoretic chamber. 
After having been able to record and estimate the magnetophoretic velocity of microparticle 
aggregations by hand, the paper presented in the next chapter addresses the problem of automatic 
data gathering. The main focus of the paper is to cover initial results using the sample application 
called blobtrack [71] from OpenCV for tracking of microparticle aggregations. The idea with this 
work is to explore improvements to the device and protocol designed and tested in [70]; and to 
provide the start point for the design of tracking software tailored for characterization of 
microcarriers intended to be used in MRN. 
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3.1 Microfluidic design 
In order to understand the importance of the magnetophoretic velocity in the MRN it is 
necessary to return to physical features that make MRN possible. These physical features will 
guide the design decisions used to fabricate the microfluidics magnetophoretic chamber. 
A general procedure in MRN can be summarized as follows: magnetic microcarriers are 
released in some predetermined point of the human vascular network (by using a catheter), then 
microcarriers are magnetically navigated through vessel bifurcations to reach the target location. 
The navigation is done following a predefined path. A schematic representation of a MRN 
procedure is shown in Figure 3-1. 
 
Figure 3-1 Schematic diagram of a general MRN procedure. 
 
3.1.1 Relevant physics principles 
As has been discussed in the precedent section, the action force used in MRN is due to a 
controlled magnetic spatial variation and is given by (Eq. 2-7): 
 =  	( ∙ )                                                   3-1 
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with M (A/m) the magnetization, and Vf  (m3) the volume of the microcarrier’s magnetic content; 
∇B  (T/m) is the magnetic gradient applied. Inside the bore of the MRI scanner there is a constant 
field denoted B0, usually big enough (1.5 T in the case of this project) to produce values close to 
saturation magnetization in the microcarrier’s magnetic content. 
 
Figure 3-2 Free body diagram. Forces on a magnetic particle (green sphere in the 
center) in the magnetophoretic chamber are depicted. The fluid flow is in x 
direction. Magnetic force is applied in y direction. In z direction acts gravity and 
buoyancy. Drag force resist movement in all directions. 
 
Figure 3-2 gives a general outline of the involved forces when a microparticle is moving in 
fluid flow. By applying the Newton’s second law of motion we obtain that: 
 =  + 67 + 	 +	=	                                                3-2 
where m is the mass of the particle and a the acceleration, Fmag is the magnetic force applied in 
the y axis, Fdrag is composed by Fdrag-x, Fdrag-y and Fdrag-z indicating fluid resistance to movement 
in all directions, finally Fg is gravitational force and Fb is buoyancy. In the context of this work, 
magnetic microparticles are supposed moving at the same speed of the fluid flow in the x axis, 
and then we consider that Fdrag-x is zero. On the other hand, movement along the z axis is usually 
neglected. The net effect of this movement in the z axis is sedimentation (when the density of the 
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magnetic microparticle is large). Sedimentation is important because it causes the magnetic 
microparticles to touch the surface of the walls of the magnetophoretic chamber, and in that case, 
friction must be considered in the motion equation. The new simplified motion equation along 
the y axis is then: 
 =  + 67>                                                3-3 
By using the simplifications exposed above, the only involved forces are the magnetic and 
the drag force along the y axis. Moreover, when particles are moving in a fluid, an equilibrium 
state is reached such that the net force is zero (acceleration becomes zero). 
0 =  + 67>	                                                3-4 
When the Reynolds number is very low (much less than 1), we have mentioned that the 
drag force Fdrag-y is given by Stokes’ drag force formula (Eq. 2-17). At equilibrium the 
magnetophoretic velocity is given by the balance between drag and magnetic forces, leading to: 
 =	67> 	= 	69:;<	 = 	 	( ∙ )                                     3-5 
with µ the viscosity of the fluid, r the particle’s radius and U the speed of the particle with respect 
to the fluid flow. The volume of the magnetic content Vf  is related to the particle’s radius r by: 
 =	 ?@9;
@
                                                            3-6 
By solving Eq. 3-5 for speed and using Eq. 3-6, the particle’s magnetophoretic velocity is 
then given by: 
< = 	2;
2(	∙	)
9:	                                                    3-7	
From Eq. 3-7 is clear that this magnetophoretic velocity can be adjusted by changing the 
size of the magnetic microcarrier (r2 term), by altering the magnetic gradient (∇B) or by 
adjusting the magnetic magnetization (M) of the magnetic microcarrier.  
This magnetophoretic velocity is a terminal steady velocity. It is important then to study the 
acceleration of the magnetic microcarrier as it approaches the steady-state to understand when it 
is possible to consider that the microcarrier has constant magnetophoretic velocity.  
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By using simplified relations in Eq. 3-5 and writing Eq. 3-3 in terms of the velocity we 
obtain the following expression: 

BC
BD
= 	  	( ∙ )	 − 	69:;C                                     3-8 
assuming the magnetic force is applied only in the y direction, the solution to this equation is: 
E(D) 	= 	 	*	F	%&69:; 	G1 −	(
HIJK
L MN	                                         3-9 
in which ∇	 is the derivative in the y axis; and M and B are the magnitudes of the magnetization 
and the inhomogeneous magnetic field. 
From Eq. 3-9, the characteristic time scale in this situation is: 
P	 = 	 69:;	                                                               3-10 
This characteristic time scale has been usually considered very small [16]. The assumption that 
the magnetophoretic velocity is the one given by Eq. 3-7 is safe in that case. However, when 
magnetic particle aggregations are being investigated, the size of the new “equivalent” 
microcarrier could increase the relaxation time due to Eq. 3-10 dependence on the mass of the 
new magnetic microcarriers aggregation. 
3.1.2 Biological considerations 
Blood flow velocity is usually very high in human vasculature. Common medium arteries 
in human are 2 mm to 6 mm in diameter, and flow velocities can range from 10 cm/s to 60 cm/s 
[72, 73, 74]. Figure 3-3 shows typical sizes and blood flow velocities in the human vascular 
system. In his work, Pouponneau et al. [5] used a bifurcation with a width of 2.5 mm to model a 
hepatic rabbit artery to test the feasibility of different ways to produce TMMCs to target liver 
cancer. In this work, it is also stated that the minimum size for microparticles used in liver 
embolization (in terms of their diameter) is 40 µm. 
Due to the fact that Eq. 3-10 indicates that the relaxation time for this kind of experiments 
can be usually considered negligible, the magnetic microparticles and magnetic aggregations 
inside the magnetophoretic chamber are considered moving with the terminal magnetophoretic 
velocity when the magnetic gradient is applied. 
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Figure 3-3 Schematic representation of human cardiovascular system vessels. 
Vessels’ main parameters depicted are inner diameter, average blood flow speed 
and Reynolds number adapted from [72]. 
 
Based on the above information, the magnetophoretic chamber was designed to be 6 mm 
wide in order to simulate most of the distances that magnetic microcarriers are expected to cross. 
Plexiglas (PMMA) was selected as the material for fabricating the magnetophoretic chamber. 
Among its advantages one can mention low cost and high transparency (vital for magnetophoretic 
experiences) [75]. 
In MRN treatments, magnetic microcarriers are normally being injected in a vessel close to 
the targeted area by using a catheter. In [4] a catheter with a lumen3 of 0.7 mm (700 µm) is used 
to perform the experiments. This diameter was selected because it did not cause the magnetic 
microparticles aggregations to clog when the injection was performed. This information is used 
to decide the size of the channel that transports the magnetic microparticles into the 
magnetophoretic chamber. In order to allow similar conditions as the ones expected in real MRN 
experiences, the width of the entrance channel is selected as 500 µm. 
In the same study [4], the designed TMMC particles are released between 20 and 30 mm 
from the bifurcation. In [76] the injection point in simulations is situated at 15 mm from the 
                                                 
3
 Lumen: size of the inside space of the tubular structure of the catheter. 
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bifurcation. This data is used to estimate that the magnetophoretic chamber should be about 15 to 
20 mm long in order to emulate previously used experimental conditions. 
As has been mentioned above, blood flow speeds for the sizes considered are quite large 
(between 10 cm/s to 60 cm/s). For a typical blood flow of 15 cm/s, the time to travel the expected 
15 mm long chamber would be 10 ms. For a frame rate of 15 frames/s (which is the typical rate 
obtained with the MRI compatible camera), one frame is taken every 66 ms; then one could not 
be able to record the movement. In order to obtain 15 frames to analyze the deflection movement 
of a magnetic particle or a magnetic aggregation, 1500 frames/s would be needed. The video 
output signals of the MRI compatible camera are NTSC or PAL video signals, which gives a 
maximum of 30 frames/s (for NTSC). With this in mind, in order to obtain several frames to 
analyze deflection patterns, fluid flow speed must be reduced. Then in order to obtain at least 7 
frames to analyze, the fluid flow should be no more than 30 mm/s. 
3.1.3 Chamber  
The initial chamber design was inspired by Pamme’s design used for continuous fluid flow 
separation [39]. In this design the magnetophoretic chamber is 6 mm by 6 mm with 16 plus 1 
inlets of 100 µm wide evenly spaced and 16 outlets of 100 µm wide evenly spaced also, designed 
as a tree like succession of bifurcations. The chip is fabricated in glass, and the flow is produced 
by a syringe pump in withdrawal mode connected in the output.  As pointed out before, the 
injection point in previous experiences was placed at 15 mm or more from the point of interest 
(bifurcation in this case). Then the design was modified to fit with the size of interest in our 
application. The number of inputs and outputs was reduced from 16 to 8 (plus the extra one in the 
input side). 
Because of the use of PMMA instead of glass and the chamber’s aspect ratio, the chamber 
was not at all functional due to deformations in the middle of the channel. Even using the pillars 
described in Pamme’s work [39], it was not possible to avoid this bending. In Figure 3-4 the 
deformation problem is schematically shown. Fluid flow moves in the x axis, the magnetic force 
is applied in the y axis and the deformation of the channel is in the z axis (not indicated). The 
resulting deformation in the z axis reduced the depth of the chamber in its center.  In such a case, 
the fluid flow tended to move around the bending zone in the microfluidic chamber as depicted in 
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Figure 3-4. In addition, the negative pressure produced by the use of the syringe pump in 
withdrawal mode increased the bending effect in the center of the magnetophoretic chamber. 
   (a) 
(b)     
Figure 3-4 Bending problem in the initial chamber design. (a) Without magnetic 
steering force applied. Magnetic microparticles are represented in blue. Stream-
lines are represented by blue arrows crossing the chamber. The bending zone is 
indicated in the middle of the chamber. (b) Expected effect on a magnetic 
aggregation when the magnetic force is applied. The expected deflection 
trajectory is shown in red; the effect of the bending zone on deflection pattern is 
shown in green. 
 
Another difficulty found with this initial approach was the tree like design of the input and 
output channels. This design was supposed to evenly spread the fluid flow in the chamber. Initial 
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tests proved that this design decision was a problem in our case, mainly because of the air 
bubbles. In any symmetric bifurcation, any perturbation can destroy the symmetry of the flow. 
The air bubbles tended to clog the branches where they stay, avoiding the liquid to flow, and then 
perturbations were produced in the flow inside the chamber. 
Based on these initial tests, the microfluidic design was modified to try to avoid as much as 
possible the problems found. The size of the magnetophoretic chamber area was reduced to 6 mm 
wide by 7 mm long. The microfluidic device is designed to measure and record microparticle 
trajectories, and not to collect them according to their magnetophoretic velocity. Accordingly, the 
input and output networks were transformed into single channels. The connection between input 
and output channels is performed in angle (Figure 3-5 (b)). The design is done taking into 
account that a right angle can produce turbulences in the fluid flow (Figure 3-5 (a)), and then the 
entrance and exit from the chamber are done in 45° in order to avoid this effect and obtain a 
smoother fluid flow (Figure 3-5 (b)).  
 
Figure 3-5 Schematics of fluid flow streamlines in channel connections. (a) 
Schematics of fluid flow streamlines for right angle channel connection with 
vortex roll forming at the entrance of the magnetophoretic chamber (adapted 
from [16]). (b) Schematic of smoothed fluid flow by using angle connection. 
 
28 
 
The input inlet for microparticles was moved to the center of the chamber in order to 
imitate the usual situation in the treatment where the catheter is expected to release the diagnosis 
or therapeutic magnetic microcarrier around the center of the selected vessel. The microparticles 
inlet is designed to be 500 µm in accordance with the inner diameter of catheters and to avoid 
clogging due to microparticle aggregations.  
The main fluid channel is designed as a bifurcation to allow the use of one syringe pump to 
produce the main fluid flow. The microfluidic device can be used in negative (syringe pump 
connected at the exit of the microfluidics in withdrawal mode) or positive pressure (syringe pump 
connected in the main flow inlet in normal mode) regime. Due to the lessons learned during the 
tests of the initial chamber design, the syringe pump is used in normal mode to alleviate the 
bending in the center of the chamber. 
In order to deal with the bending of the center of the chamber, various bonding techniques 
were tried. Bonding of PMMA plates is done using an oven, where the pressure and temperature 
can be controlled. The right balance between pressure and temperature allows the minimization 
of the deformation effect in the microfluidic device. The glass transition temperature for PMMA 
is around 105 ºC. At this temperature, PMMA starts to soften, if pressure is then applied to the 
PMMA substrates, they affix together. The problem is that as PMMA softens, the substrate can 
change its geometric properties during the bonding process.  
The following PMMA bonding techniques were tried:  
• Low pressure, high temperature bonding: a relatively high temperature of 165 ºC is used, 
and in order to avoid channel deformations, very low pressures are needed [77]. The 
results when using this technique were worse than what was obtained with the typical 
configuration of the oven usually used in the Nanorobotics Lab. 
• Low temperature, high pressure bonding: the idea in this case is that the PMMA substrate 
is kept below the glass transition temperature 95 ºC which ensures its rigidity during 
bonding [75]. Again results when using this technique were worse than what was obtained 
with the typical configuration of the oven usually used in the Nanorobotics Lab. 
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• Thermal bonding in water: in this technique PMMA substrates are clamped together and 
immersed in boiling water during 1 hour [78]. The results were even worst with this 
technique. The PMMA plates were completely deformed during the process. 
In the end, the bonding method used in this work was based on the previous settings of the 
oven with some slight variations in order to decrease the bonding temperature and pressures such 
that the geometry of the chamber was better maintained. 
 
Figure 3-6 Flow pattern in the magnetophoretic chamber. Flow observed in the 
magnetophoretic chamber when ink is pumped in the microparticles inlet and DI 
water in the main flow inlet. 
 
In order to verify that the chamber was going to direct particles to the center of the 
magnetophoretic chamber and to calibrate the relationship between syringe pump speeds, 
experiments were performed by injecting ink in the microparticles inlet, while DI water was 
pumped in the main flow inlet. Once calibrated, the observed flow pattern is shown in Figure 3-6, 
it can be noticed that ink flow goes straight forward to the outlet of the chamber. It can also be 
noticed that laminar flow has been achieved as the size of the ink flow has a relatively constant 
width, which indicates that no turbulences are observed. 
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3.2 Microparticles 
As mentioned before, TMMC have been designed in our laboratory and have been already 
demonstrated [4]. The obvious choice for magnetic microparticles to try the magnetophoretic 
chamber was to use TMMC, however these were not available. These microparticles were 
produced in limited quantities to demonstrate that it is possible to produce magnetic loaded drug 
carriers for use in MRN tretaments. Then it was needed to select ones with similar characteristics 
to the TMMC used in [4]. TMMC have a mean diameter of 53 µm, are polydisperse and have a 
magnetization of 250 kA/m. 
PS-MAG-S1986 microparticles from Microparticles GmbH (Berlin, Germany) were used 
in this project. These microparticles have a mean diameter of 41.13 µm, are monodisperse, and 
have a magnetization of 36 kA/m in a field of 1.5 T as typical found in clinical MRI scanners4.  
These microparticles exhibit a diameter almost equivalent to the TMMC that have been 
successfully navigated in the hepatic artery of rabbit models with controlled release of the 
therapeutic agent in specific locations in the liver [4]. Moreover, in [5] it is established that 40 
µm is the minimum average diameter for embolization, then even if there are other commercially 
available magnetic microparticles with a magnetization values closer to the TMMC ones, their 
diameter was much lower than 40 µm, then PS-MAG-S1986 microparticles were preferred. 
3.3 Simulations 
Based on Eq. 3-3 and Eq. 3-8, a simulation framework was designed to evaluate the 
possible outcomes of the experiences using the magnetophoretic chamber described in the 
previous section. The simulations were done using Matlab. 
The simulation is a very simplified version of Joerg Buchholz’s Particle System Toolbox 
[9]. Basically time is divided into steps that are used to evaluate the acceleration in the y axis as 
expected from Eq. 3-8. Then velocity and position in the y and x axis are evaluated by using the 
following relationships: 
                                                 
4
 Monodisperse: particles have uniform size distribution. Polydisperse: particles have varied sizes distribution 
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As can be seen, the velocity in the x axis is assumed to be constant because it corresponds to fluid 
flow acquired velocity. The simulation starts when the particle arrives at the magnetophoretic 
chamber, and so, the initial y axis velocity is assumed to be zero. 
Simulation results were used to compare experimental findings with theoretical ones in a 
conference paper [70]. There is no study on the influence of the initial position in this simulation. 
Microparticles are supposed to be perfect spheres to evaluate the drag force. Possible existing 
friction forces and gravity have been neglected for the purpose of this initial screening of the 
expected results by using the magnetophoretic chamber. 
Due to the reasons exposed before, 4 fluid flow speeds have been selected with a maximum 
of 20.8 mm/s. The other 3 fluid flow velocities were chosen to be successive speed halves (i.e., 
10.4 mm/s, 5.2 mm/s and 2.6 mm/s). In this way it is expected to be able to study the effect of the 
fluid flow on deflection patterns of magnetic particles and magnetic aggregations when a 
magnetic gradient is applied. 
Simulation results are shown in Figure 3-7. The low magnetization of the magnetic 
microparticles used could explain that it is not expected that they will be able to cover 
individually the 3 mm trajectory in the y axis for any of the flow velocities considered. The 
simulation parameters used in this simulation are shown in Table 3-1. 
The resulting individual microparticle magnetophoretic velocities (measured as the distance 
reached in the y axis while 7mm have been reached in the x axis, divided by the time that this 
takes) are: 69 µm/s at a fluid flow of 20.8 mm/s; 153 µm/s at 10.4 mm/s; 304 µm/s at 5.2 mm/s 
and finally 534 µm/s at 2.6 mm/s. 
If real human flow speeds are considered, it is not expected that individual microparticles 
are going to be able to travel the 3 mm distance in the y direction due to the action of the 
magnetic force. Initial simulation results show that if using the magnetic microparticles 
considered here, the blood flow should be slowed down (this has been done before using 
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catheters with a ballon on its end). However 3 mm is considered the worst case scenario. What is 
really needed is that the magnetic microcarriers should reach the fluid flow streamlines that are 
going to permit them to enter the expected bifurcation branch, then most of the distances that they 
have to traverse are much less than the worst case scenario. 
 
 
Figure 3-7 Simulated individual microparticle’s deflection patterns. Flow 
velocities considered are 20.8, 10.4, 5.2 and 2.6 mm/s (from top to bottom in the 
graphic). 
 
Table 3-1 Simulation parameters 
Name Units Value 
Microparticle diameter m 41.13 × 10-6 
Microparticle mass kg 9.035 × 10-7 
Microparticle magnetization A/m 36 × 103 
Magnetic gradient T/m 0.4 
Water viscocity Pa·s 0.001 
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The next question to respond by simulation was the effect of magnetic aggregation on the 
trajectories of the magnetic microcarriers. According to [79], 280 magnetic microparticles can be 
safely used in the form of bolus injections allowing not blocking the tip of the catheter. The 
theoretical therapeutic treatment followed in this way would last around 30 minutes with the 
injection of about 380 of such boluses every 5 seconds approximately. In such case, the total 
mass using data inTable 3-1 would be 2.53 × 10-4 kg and an equivalent sphere with the same 
volume as 280 microparticles in chain like aggregation would be 308.0 × 10-6 m (the derivation of 
this diameter value can be found in the Appendix 1). The resulting expected trajectories for 
magnetic aggregations of 280 magnetic microparticles are shown in Figure 3-8. 
  
Figure 3-8 Simulated microparticles aggregations deflection patterns. Flow 
velocities considered are 20.8, 10.4, 5.2 and 2.6 mm/s (from top to bottom in the 
graphic). 
 
The resulting final magnetophoretic velocities are: 107.34 µm/s at a fluid flow of 20.8 
mm/s; 251.25 µm/s at 10.4 mm/s; 541.21 µm/s at 5.2 mm/s and 1.11 mm/s at 2.6 mm/s. In this 
case one should expect that magnetic aggregations of the size as the ones proposed in [79] should 
traverse the entire y axis of the chamber only in the case of the lowest fluid flow velocity. 
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3.4 Experiments 
The experiments were designed to test the viability of the magnetophoretic chamber as the 
base for future developments to study the deflection behavior of magnetic microparticles 
subjected to a magnetic force. One of the main objectives of the experiences is to study magnetic 
microcarriers aggregation by evaluating their response to a magnetic gradient. From simulations 
shown before, it seems clear that, even if the size of the magnetic material is increased (by using 
dipole-dipole interaction between magnetic microparticles), the main obstacle to control magnetic 
microcarriers is the fluid flow speed in the human body. 
3.4.1 General setup 
The experimental setup consist of a PMMA phantom, designed following the process 
mentioned before, positioned in the center of a custom built Maxwell pair coil generating the 
magnetic gradients. The whole system is placed in the middle of the bore of a commercial MRI 
scanner providing the constant 1.5 T main magnetic field. 
Two syringe pumps are used to control the main and magnetic microparticles fluid flows. 
Magnetic microparticles are introduced in the fluid flow by using a 3-way switch placed inside 
the MRI scanner bore. This way of injection was selected instead of pumping microparticles from 
outside the MRI scanner bore; because in the vicinity of the entrance to the MRI bore the 
magnetic field is not constant, then magnetic aggregations tend to move in an uncontrollable 
fashion. Moreover, syringe pumps must be placed around 2 m far away to avoid the magnetic 
force in the vicinity of the MRI bore act on them, then magnetic microparticles tend to sediment 
in the tubing before reaching the PMMA microfluidics. This procedure is based on the 
methodologies described by J.B. Mathieu in his thesis [69]. 
The Maxwell pair coil is able to produce 22.15 mT/m for each A, at 18.05 A produces 
approximately 400 mT/m. It has a rise time of 10 ms. Each coil has a diameter of 12 cm and the 
space between them is 10 cm. The Maxwell coil pair is driven by a KIKUSHI PBX 20-10 bipolar 
power supply manually controlled. The microfluidic device is oriented perpendicular to the main 
static field B0 of the MRI scanner. The magnetic gradient generated by the Maxwell pair is 
oriented parallel to the main static field. 
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3.4.2 Experimental results 
The initial experiences showed good agreement with the expected results for aggregations. 
At lower flow speeds (2.6 and 5.2 mm/s) simulation results seem to fit relatively well with 
experiments. Supposing rod-like aggregations as in Figure 3-8, for a flow speed of 5.2 mm/s the 
experimental magnetophoretic velocity was 44% faster than simulated one, and in the case of 2.6 
mm/s experimental magnetophoretic velocity was 14% faster than simulation result. The results 
were presented in a conference paper in the International Conference on Manipulation, 
Manufacturing and Measurement on the Nanoscale (3M-NANO 2012). The deflection patterns 
were similar to the ones shown in Figure 3-8. As expected from simulations, the only case in 
which the aggregations were able to cover the 3 mm distance was for a fluid flow velocity of 2.6 
mm/s. 
The main problem with this initial setup is the fact that magnetic microparticles are 
relatively heavy, and then sedimentation cannot be safely neglected, which could explain 
differences with simulations. Another problem is the injection methodology, the control of 
aggregates dimensions and shapes is not the subject of this investigation, but a better controlled 
way to inject and produce magnetic microparticle aggregations could certainly be beneficial in 
magnetophoretic experiences. 
Initial magnetophoretic velocities for magnetic aggregations were estimated as 0.95 mm/s 
in a fluid flow speed of 2.6 mm/s, 0.78 mm/s in a fluid flow speed of 5.2 mm/s, 0.90 mm/s in a 
fluid flow of 10.4 mm/s, and 0.92 mm/s in a fluid flow of 20.8 mm/s. These measurements were 
done by hand counting the number of frames and the total distance that the aggregations have 
travelled from the first frame magnetic force is applied through the end of its deflection trip. 
These results compare relatively well with simulation results shown for rod like aggregations, 
especially for the fluid flow speed of 2.6 mm/s where simulations indicate 1.11 mm/s and 
experimental results show 0.95 mm/s.  
3.5  Tracking tool 
After promising results from the magnetophoretic chamber, it was decided to investigate 
the feasibility of using a software tracking tool to integrate with the magnetophoretic chamber, 
then creating a complete magnetophoretic behavior testbench. 
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The paper presented in the following chapter shows the results of applying a modified 
version of the OpenCV blobtrack [71] sample application to track magnetic particle aggregations 
in the magnetophoretic chamber. This tracking tool was used in Peng’s thesis [8] to track 
aggregations when using a fuzzy controller.  
After these tests it was decided to develop a software tool specific for magnetophoretic 
experiments. The software tool is designed to present a solution to the goal of identify moving 
particles in digital videos taken from magnetophoretic experiences and to obtain the 
magnetophoretic velocity by following their movement, taking into account the specificities of 
the magnetophoretic experiences instead of using a general tracking tool as the blobtrack one. 
The initial step was to decide the adequate development platform and tools to develop it.  
The tool is developed in C++ because it has the following advantages: 
• it is a language that has good support for mathematical and graphics processing, 
• it allows good modularity which allows better comprehension of the software and makes 
it easier to change, and 
• it provides high and low level programming options. 
In order to get the image processing tools, it was chosen to continue using OpenCV due to 
the following characteristics of it: 
• as indicated before, there is some exposition to it in other projects, then this knowledge 
can be used in this project, 
• it is a mature open source initiative (more than 10 years of development), 
• it includes several image processing tools proven methods for object tracking, 
• it is compatible with C++ programing language, in addition with Python support for rapid 
prototyping, 
• it has an active internet community allowing easy access to support and examples, and 
• it is a cross-platform tool (supports Windows, Linux, iOS and Android). 
Finally in order to develop a GUI for the tracking software tool, Qt was selected due to:  
• its integration with OpenCV,  
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• it is an open source framework,  
• it provides a comprehensive set of tools for GUI development, and 
• it is cross-platform. 
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4.2 Abstract 
An experimental setup for characterizing the magnetophoretic properties of magnetic 
therapeutic microcarriers and/or diagnostic agents is described. Such characterization is essential 
for determining the optimal sequences of magnetic gradients to deflect its trajectory through 
relatively complex vascular networks in order to reach a predetermined target. The recorded 
magnetophoretic data can be used to predict the path of the agents when submitted to directional 
gradient fields and under different fluid flow velocities. Automatic extraction of these data is 
performed using a tracking method. 
4.3 Introduction 
Minimally invasive cancer treatments have recently aroused much interest. Magnetic 
Resonance Navigation (MRN) is a technique aimed at navigating magnetic microcarriers [3, 50, 
51] such as Therapeutic Magnetic Micro Carriers (TMMC) [4, 5] for drug delivery in cancer 
therapy. This drug delivery system promises improvements in therapeutic and diagnosis by 
increasing targeting efficacy while avoiding or at least minimizing systemic circulation often 
causing added toxicity in healthy organs. 
The basis of this method consists in the use of the magnetic homogenous field and the 
magnetic gradients of an upgraded clinical Magnetic Resonance Imaging (MRI) scanner to 
magnetize the soft magnetic nanoparticles inside the microcarriers and to steer them respectively 
along a planned trajectory in the vasculature towards a targeted destination. This method has been 
validated in-vivo in [3, 4]. 
With a reduction of the size of the magnetic drug carriers to accommodate narrower blood 
vessels, the amount of therapeutics being delivered is reduced as well. To compensate, magnetic 
aggregations of MR-navigable therapeutic microcarriers are used. Such magnetic aggregations of 
microcarriers will be characterized with magnetophoretic velocities [6, 52] which differ from 
single microcarriers. 
As a consequence, collecting reliable data such as with an optical method [23] on the 
magnetic responsiveness in term of deflection patterns of such magnetic microcarriers is critical 
for determining the optimal control sequences during MRN in order to achieve a higher Magnetic 
Resonance Targeting (MRT) efficacy with a given type of MRN-compatible agent during 
40 
 
targeted medical interventions. Indeed, several types of such therapeutic agents could be 
synthesized with various sizes, while embedding a larger quantity of magnetic nanoparticles to 
enhance responsiveness to magnetic gradients or with less magnetic nanoparticles to allow a 
higher density of therapeutics to be delivered. In turn, a higher or lower concentration of 
magnetic nanoparticles within each microcarrier will affect the dipole-dipole interactive forces 
among neighbored microcarriers which would have a profound impact on the overall magnetic 
response of the aggregates to specific magnetic gradients. 
The importance of aggregation has been addressed in several works. In [53], Vartholomeos 
et al. argue that magnetic aggregation could be used to increase therapeutic effectiveness of 
aerosol drug delivery for lung treatment while in [57] Riegler et al. explore the aggregation of 
labeled cells for use in cell transplantation therapy. References [6, 52] suggest that 
magnetophoretic velocity of aggregations and the fraction of aggregated versus non-aggregated 
particles needs to be precisely estimated in order to get better targeting predictions prior to 
conduct MRN. 
The goal of this study is to design and test a magnetophoretic testbench. The initial results 
with the testbench were presented in [70]. 
In order to build a useful tool for characterization of new therapeutic/diagnostic 
microcarriers, the testbench must include some sort of automatic tools. As has been discussed 
above, the range of variability between magnetic microcarriers can be very large. On the other 
hand, the statistical meaning of the measurements is governed by the capacity to manage a big 
enough amount of runs each time a new microagent is evaluated. As pointed out in [70], a major 
drawback of the current design is the need to synchronize the magnetic gradient with the entrance 
of particles in the magnetic chamber. It is also clear that, even if another chamber design solves 
this inconvenient, software for detection and tracking of the microparticles aggregations is 
needed. An initial evaluation of the feasibility of the detection and tracking is discussed here. 
The testbench is experimentally tested by measuring the magnetophoretic velocity of MRN 
microcarriers relying on embedded nanoparticles in the bore of a clinical MRI scanner; and 
evaluating the effect of the flow rate on the deflection of these magnetic micro-entities. The 
results presented in [70] are used to evaluate the tracking method for data detection and 
acquisition. 
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4.4 Theoretical background 
4.4.1 Particle movement 
The magnetic propulsion force induced by a magnetic gradient ∇B on a magnetic particle 
or magnetic aggregation is: 
Fmag = Vf	(i ∙ j)k     4-1  
where Fmag is the magnetic force (N), M is the magnetization of the material (A/m), Vf is the 
volume of the magnetic entity (m3) and ∇B is the spatial variation of the magnetic field (T/m). 
The laminar flow in a pipe is characterized by the Reynolds number that can be computed 
as 
Re	 = 	UolowD	ν            4-2  
where Uflow (m/s) is the fluid flow velocity in the main direction, D is the diameter of the pipe 
(m) and ν (m2/s) is the kinematic viscosity of the fluid. In the case of a rectangular pipe, the 
equivalent diameter is the hydraulic diameter defined by 
Dh	 = 4AP 	      4-3  
where A (m2) represents the cross sectional area and P (m) the wetted perimeter. If Re < 2,100 the 
flow in the pipe is considered laminar [80]. 
In addition, the viscous drag force that acts on a spherical particle is governed by Stokes' 
law when the spherical object is moving in a fluid and it is characterized by a low Reynolds 
number (< 1) 
Re-p	 = 	UDpν-1	 = 	2Ur	ν-1	    4-4  
where Dp = 2r is the diameter of the particle (m) and U is its velocity. Then the Stokes drag 
force is 
Fd	=	6πμr	U      4-5  
where µ is the dynamic viscosity of the fluid. 
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In the case of a particle moving in a liquid, the magnetic force balances with the drag force 
[81] leading to the magnetically induced velocity 
Umag	=	Fmag	(6πμr)-1      4-6  
Replacing Eq. 4-1 in Eq. 4-6 leads to: 
Umag	=	Vf	(M∙∇)B	(6πμr)-1         4-7  
if all parameters are left constant with the exception of the size of the particle, the velocity 
acquired by the particle from the magnetic force in function of its radius is 
Umag	=	Kr	2       4-8  
with 
K	=	2M∇B(9μ)-1          4-9  
which clearly shows that increasing the size of the magnetic entity leads to an increase in the 
magnetic induced velocity proportional to the square of the radius of the particle [23]. 
On the other hand, we can state that the velocity of a particle in a flow and under the effect 
of a magnetic gradient is given by 
Udeol	=	Umag	+	Uolow
 
 
   4-10  
where Umag is given by Eq. 4-1 and Uflow is the velocity acquired by the particle due to the fact 
that is moving with the flow [39]. From Eq. 4-10 is clear that, if all other parameters are constant, 
the deflection pattern is governed by the fluid flow velocity. 
Then, if Eq. 4-8 is re-arranged 
Umag	μ=	2r2M∇B
9	       4-11  
the product of the magnetophoretic velocity by the viscosity of the fluid is constant for a given 
particle in a given gradient. With which, by knowing the magnetophoretic velocity of the 
microparticle in water, there is a way to roughly estimate the magnetophoretic velocity of the 
particle in other non-aqueous media (e.g. blood) if the viscosity of the new fluid media is known 
Unew_media	=	Umag_water	μwater/μnew_media
 
 4-12  
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4.4.2 Particle tracking algorithm 
Tracking is a non-trivial task, even in controlled environments. In order to evaluate the 
automatic detection and tracking of magnetic microcarrier aggregations, the OpenCV [82] library 
is used. The OpenCV library comes with a sample application called blobtrack [71] designed to 
track objects moving with respect to a static background. The general algorithm is described in 
[83], basically it performs a video frame segmentation, motion detection and trajectory update. 
The input video frame is used to estimate the background. The background is then 
subtracted from the video frame. The resulting foreground frame is divided into regions that are 
grouped into connected components. By analyzing the connected components, it can be 
determined if each the region is: an existing object, a new object, there is a merge detected 
between objects, or there is a split detected for an object [84]. 
4.5 Experiments 
4.5.1 Microparticles for magnetophoresis measurements 
To characterize and validate the method and the proposed system, PS-MAG-S1986 
microparticles from Microparticles GmbH (Berlin, Germany) were used in this study. These 
microparticles have a mean diameter of 41.13 µm, are monodisperse, and have a magnetization of 
36 kA/m in a field of 1.5 T as typical found in clinical MRI scanners. Although not quite at 
saturation, the microparticles are considered at saturation magnetization for the purposes of this 
report. 
These microparticles were also selected because they exhibit a diameter almost equivalent 
to the TMMC that have been successfully navigated in the hepatic artery of rabbit models with 
controlled release of the therapeutic agent in specific locations in the liver [4]. 
4.5.2 Microfluidic design and fabrication 
The microfluidic chamber as depicted in Figure 4-1 is designed to be 6 mm wide by 7 mm 
long with a depth of 200 µm. It has two inlet channels and one outlet channel. One of the inlet 
channels is used to inject microparticles and has a width of 500 µm; the other inlet is used to 
44 
 
provide the main flow, and it has a width of 1 mm. The main flow channel is bifurcated into two 
branches of 500 µm in order to allow injection of microparticles in the middle of the main flow. 
Then two main flow branches of 500 µm are combined with the microparticles inlet channel to 
produce an input channel of 2 mm. The output channel width is 2 mm. The entrance and exit to 
the magnetophoretic chamber are done by widening and narrowing the channel width. All the 
system has rectangular cross section with a depth of 200 µm. 
 
Figure 4-1 Schematic of the microfluidic device design. The complete device is 
200 µm deep. Magnetophoretic chamber is 7 mm × 6 mm. Main flow and 
microparticles flow meet in the 2 mm entrance channel. 
 
The microfluidic device was fabricated by milling the channels in a 1.5 mm thick 
poly(methyl methacrylate) (PMMA) sheet; the cover plate is another 1.5 mm thick PMMA sheet 
with access holes drilled on it. Both sheets are thermally bonded to form the microfluidic device. 
The dimensions of the microfluidic chamber were selected such that a low Reynolds 
number is obtained for the fluid flow velocities used in the experiences. The hydraulic diameter 
Dh for the chamber is 387.1 µm, the maximum fluid speed used to perform the experiments is 
20.8 mm/s, and the kinematic viscosity of water is 10-6(m2/s). By putting these values in Eq. 4-2, 
the maximum Reynolds number for the chamber is Re = 8.05 ≪ 2,100, which ensures laminar 
flow inside the microfluidic chamber for all the fluid speeds considered. The laminar 
characteristic of the flow was anyway investigated by injecting ink in the microparticles inlet as 
explained in [70]. The Reynolds number for a microparticle moving in the flow is Re_p = 0.05, 
which means that the Stokes law can be safely used for the case of individual particles. 
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4.5.3 Experimental setup 
The magnetic suspension of microparticles has a concentration of 0.83 mg/ml and the 
suspending fluid is deionized (DI) water. The microfluidic device is placed in the center of the 
bore of a 1.5 T Siemens Avanto MRI scanner (Siemens, Erlangen, Germany) (Figure 4-2). A 
custom built Maxwell pair gradient coil is used to generate magnetic gradients. In this work, the 
gradient amplitude is always 400 mT/m. An MRI-compatible camera (MRC Systems GmbH, 
Heidelberg, Germany) is used to record the movement of the microparticles. The camera is 
located above the magnetophoretic chamber to allow monitoring the entrance of microparticles in 
the magnetophoretic chamber and records video at 15 frames/s. 
Two syringe pumps are used to control the microparticles flows. The experiment is done by 
observing the deflection patterns at flow velocities of 2.6, 5.2, 10.4, and 20.8 mm/s. The 
microparticles are carried by the flow; therefore, if no magnetic gradient is applied, they travel in 
a straight line to the outlet. The microfluidic device is oriented such that the flow is perpendicular 
to the main static field B0 of the MRI scanner. The magnetic gradient is oriented parallel to the 
main static field. 
The experimental protocol is as follows: start video recording, apply flow with the syringe 
pumps, as the microparticles are detected arriving to the magnetophoretic chamber turns on the 
magnetic gradient and when the microparticles finish its traveling through the magnetophoretic 
chamber, it turns off the gradient. The gradient is applied each time new microparticles arrive to 
the chamber. 
4.6 Results 
4.6.1 Experiments results 
As mentioned above, the microfluidic chamber was tested in order to verify that at the fluid 
flow speeds considered, steady flow is expected. Figure 4-3 shows typical deflection patterns 
observed in each one of the flow velocities investigated. Each one of the inserted figures shown is 
formed by superposition of frames taken from the videos. For trajectories shown in Figure 4-3 the 
estimated magnetophoretic velocities are: for Figure 4-3a: 0.92 mm/s, for Figure 4-3b: 0.90 
mm/s, for Figure 4-3c: 0.78 mm/s, and for Figure 4-3d: 0.95 mm/s. For more details refer to [70]. 
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Figure 4-2 Schematic of the experimental setup. Prop Coil 1 and Prop Coil 2 
refer to the custom Maxwell pair coils. It is seen that the fluid flow and magnetic 
gradient are intended to be orthogonal. Then all movement perpendicular to the 
flow is solely produced by the magnetic gradient from the propulsion coils. 
 
 
Figure 4-3 Effect of the fluid flow velocity on the deflection pattern of magnetic 
microparticles aggregations moving along the magnetophoretic chamber, in (a) 
the fluid velocity is 20.8 mm/s and it is difficult to notice the deflection of 
microparticles; in (b) the fluid velocity is 10.4 mm/s; in (c) fluid velocity is 5.2 
mm/s, and in (d) it is set to 2.6 mm/s 
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Figure 4-4 Comparison between the tracking software applied to raw video (left 
side) and to filtered frames video (right side). Only for the slower fluid velocity 
is possible to extract directly from raw video the trajectory of magnetic 
microparticle aggregations 
4.6.2 Tracking experiments 
The movies obtained in [70], used to initially estimate the magnetophoretic velocities of the 
magnetic aggregations, are used as a starting point to evaluate the option of using the OpenCV 
library to track and to compute automatically the magnetophoretic velocities of the microcarrier 
aggregations. Figure 4-4 shows the initial attempts with the raw videos obtained in the 
experiments, compared with the tracking done to the same videos but filtered before being treated 
for tracking and detection. 
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4.7 Discussion 
As shown, the microfluidic device accomplished the task of allowing the observation of the 
magnetophoretic mobility for magnetic microparticles aggregations. However some limitations 
have emerged from the experiences. For instance, the magnetic gradient needs to be applied at the 
entrance of the magnetophoretic chamber otherwise the magnetic aggregations tend to follow the 
direction of the main flow. This means that if more than one aggregation reaches the 
microparticles inlet channel, those aggregations that have not reached the magnetophoretic 
chamber show a pronounced deflection pattern, but this behavior is due to the fact that 
microparticles aggregations get to the vicinity of the walls of the inlet channel and therefore 
follow the lines of flow from the main stream. 
Another limitation of this setup is the fact that gravity is being neglected. The effect of 
gravity is not taken into account because the magnetophoretic chamber is studied from the top 
and vertical movements are not recorded. This limitation affects measurements especially at low 
flow speeds, because the more time the aggregations are in the magnetophoretic chamber, the 
more likely is that they are going to settle. 
The mentioned limitations have not prevented us to get data on the way in which 
aggregations behave under different flow speeds. As mentioned above, we assume that 
aggregations are around the same size in each of the measurements done. The optical equipment 
used allows us to estimate aggregation sizes above 100 µm, but on the other hand, the size of 
aggregations seems to be limited by the size of the inlet used to inject them. 
The initial results with the OpenCV library establish clearly the need of a calibration 
protocol before each one of the experiences in which characterization data is going to be 
gathered. The adjustment of contrast and brightness must be performed initially, followed by a 
step to learn the background such that the recognition of the moving objects that are going to be 
tracked and that belong to the foreground becomes more easy and accurate. This background 
learning process seems clear from the first couple of images in Figure 4-4 in which becomes 
apparent a spatial regular noise that the software recognizes as particles someway appearing in 
vertical positions, which could be attenuated with an appropriated spatial low pass filter. It seems 
clear also that a higher speed video camera would produce much better results, even though it 
could mean process the video data sometime after instead of in an immediately manner. As the 
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testbench is intended to evaluate the magnetic characteristics of the micro-entities before they are 
to be used as treatment and/or diagnostic vectors, this last limitation appears to be minor. It is 
more important to get the right data than to get it earlier. 
Another way to cope with the problems of the video quality could be to use lower fluid 
flow velocities in order to detect and track the aggregations safely. Considering that fluid flow 
velocities less than 2.6 mm/s are far from blood flow velocities in some of the more important 
arteries [73], this last option needs to be evaluated carefully. The importance of the testbench 
protocol design is to reflect as closer as possible the deflection patterns that the magnetic 
microcarriers are going to show inside real vascular environments in patients. 
4.8 Conclusions and future work 
In this study, a microfluidic device has been designed to evaluate the effect of the fluid 
flow velocity on the deflection pattern of magnetic aggregations. Preliminary results show that 
this device allows magnetophoretic velocity estimations at different fluid flows, and thus, allows 
characterizing drug or diagnosis magnetic microcarriers containing different magnetic 
nanoparticle content. Even though the detection and tracking of the microparticle aggregations in 
situ is still challenging, post processing of the data could cope with this limitation. Fundamental 
investigations on this specific subject are usually theoretical and experimental data could lead to 
new applications of microcarriers. This is the first step in the direction to produce a testbench for 
micro-entities to be used in MRN. The knowledge about microcarriers' deflection patterns should 
allow better predictions of targeting efficacy. 
Future work includes other magnetophoretic chamber designs with the microparticles' inlet 
being positioned such the magnetic gradient does not need to be synchronized with the entrance 
of particles or aggregations to the magnetic chamber, a design inspired from the work done in 
[39]. Another interesting chamber design to try is one based on the work from Carr et al. [85], in 
which the microfluidic chamber is positioned vertically instead of horizontally, a way in which 
friction forces with the walls of the microfluidics related to settling of particles is avoided. 
It is necessary also to verify the behavior of magnetic aggregations when the gradient force 
is applied perpendicular to the main field. Some simulation studies suggest that the angle of the 
chain like aggregation with respect to the gradient could play an important role in targeting 
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efficiency [76]. As microfluidic magnetophoretic chambers are used for separation and sorting 
purposes, the next generation of devices will include several outlets to estimate the fraction of 
aggregated versus non aggregated microparticles. 
In parallel the detection and tracking system, including the software tools and experiences 
protocol, must be refined to allow improved data gathering on the deflection trajectories. Finally 
for the tool to fully accomplish its use, a magnetic microcarriers’ database must be designed to 
collect the data obtained. In this respect a relational database design (SQLite 
[http://www.sqlite.org/]) and object-oriented approach (db4o [http://www.db4o.com]) are under 
consideration due to the requirements of the system. 
4.9 Acknowledgments 
The authors would like to thank particularly Charles Tremblay, Ke Peng, Alexandre Bigot, 
Nina Olaemei, Viviane Lalande, and Manuel Vonthron from NanoRobotics Laboratory, for their 
suggestions and their support to this project. The blobtrack sample code used in this work was 
initially modified and tested by Behnam Izadi. 
 
51 
CHAPTER 5 PROPOSED TRACKING METHOD 
 
As the OpenCV blobtrack application was already used in other project in the laboratory, 
initially it was reused as the data gathering tool when tracking microparticle aggregation 
movements in the magnetophoretic chamber. In this chapter the blobtrack application initial trial 
usage is described. Then, taking into account the lessons learned, a new tailored tracking tool 
based in a translational model is proposed and initial results of its use are presented. 
5.1 Tracking using OpenCV blobtrack 
As mentioned in Chapter 3, the blobtrack application from OpenCV was used to evaluate 
the automatic detection and tracking of magnetic microcarrier aggregations. The general 
algorithm is described in [83], basically it performs a video frame segmentation, motion detection 
and trajectory update. The input video frame is used to estimate the background. The 
foreground/background differentiation algorithm used in the blobtrack application is the one 
presented in [86]. This method is based on a Bayes decision rule applied to probability density 
functions assigned to the pixel values. The background image is updated gradually from the input 
image sequence by assuming that pixel values have relatively few changes for stationary 
backgrounds and that pixel value changes for moving background are similar and happen in the 
same place of the image [86]. The background is then subtracted from the video frame. The 
resulting foreground frame is divided into regions that are grouped into connected components. 
By analyzing the connected components, it can be determined if each the region is: an existing 
object, a new object, there is a merge detected between objects, or there is a split detected for an 
object [84]. The algorithm used for foreground segmentation is described in [84] and is 
implemented using the OpenCV contour finding function based on [87]. A contours list is 
generated, according to size too small blobs are removed, others are removed if there is 
intersection between them (the track is done to just one of them until they separate enough) and 
the same distance measure is used to detect new objects [84]. The distance measurements used to 
detect intersection between blobs are represented in Figure 5-1. If the distance between the 
centroids of the blobs is less than the sum of the halves of their widths and heights, then they 
intersect. Finally the list of blobs is bubble sorted and only the first 10 biggest blobs are kept. 
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Figure 5-1 Distance measurement to detect blob intersection. The quantities d1 = 
x2 - x1 and d2 = y2 - y1 are horizontal and vertical distances between centroids of 
the blobs, w1, w2 are the widths and h1, h2 are the heights of the blobs 
respectively. If d1 < (w1/2 + w2/2) ˄ d2 < (h1/2 + h2/2) the blobs are considered 
merged. 
 
By default, the blobtrack application uses two methods to track object position and size: a 
simple connected-component tracker and a more complex tracker based on a hybrid 
implementation of a particle filter weighted by mean-shift measurements. Mean Shift algorithm 
is an iterative procedure that looks for maximize a similarity metric, which usually is the 
Bhattacharryya coefficient [88]. In particle filtering the objects are represented as state variables, 
the aim of the algorithm is to estimate the state of the object given previous state measurements, a 
weighted sample set is used to represent conjectured object states [89]. 
In Figure 5-2, the detected aggregations in different frames alongside with the calculated 
foreground (resulted from subtracting the background to the current frame) are shown for the 
fluid velocity. In this figure it can be noticed that some illumination problems caused noise that 
could result in spurious detected particles. The source for the illumination problem can be 
attributed to the fact that inside the bore of the MRI scanner some vibration is induced by the 
cooling system of it. This vibration caused the illumination slightly and periodically change, and 
these changes were interpreted by the tracking software as new objects. In Figure 5-2 there was 
two chain like aggregations, one moving from left to right (the highlighted one) and another one 
at a standstill positioned left from the first one. The tracking software is expected to detect only 
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the moving chain like aggregation, and maybe, the stand still one. All other detected objects are 
due to noise. 
 
Figure 5-2 Detected aggregations in different frames. Accumulated detected 
particles at different points in time are shown at left. Foreground resulted by 
background subtraction from current frame is shown at the right. The video used 
is the one at which the fluid velocity is 2.6 mm/s. Particles detected are 
highlighted with a circle surrounding them. 
 
 The blobtrack application is primarily intended for general surveillance applications. Then 
it contains several modules with algorithms that were not used for this project. In order to get 
better results in identifying chain like microparticle aggregations a prefiltering process was 
designed. The process followed in a frame basis is: decrease brightness (by using cvAddS 
function), increase contrast (by using cvScale function), simple mean filter smoothing (cvSmooth 
with CV_BLUR option) and binary thresholding (cvThreshold with CV_THRESH_BINARY). 
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Blur smoothing is used to reduce the effect of noise in images, and thresholding is used in order 
to eliminate, as much as possible, image artifacts that could be interpreted as particles. In the case 
of higher fluid flow speeds, the software is not able to track the magnetic microparticles 
aggregations, even when the human eye is capable to distinguish their movement. In this case the 
microparticles were marked by hand. The results are shown in Figure 5-3 for the same frames as 
in Figure 5-2. The first column shows the result of reducing brightness in frames 7, 13 and 20. 
The second column shows the result of increasing the contrast in frames 7, 13 and 20; it is 
interesting to note that chain like aggregations seem less visible in this step.  The next step 
applied to mentioned frames is shown in Blur column with the smoothing process intended to 
enhance chain like aggregation appearance by making more uniform the regions of relative 
similar color. The final column shows the thresholding process by which chain like aggregations 
are more easily highlighted. 
 
 
Figure 5-3 Filtering process example applied on the same frames as in Figure 
5-2. The tracked aggregation is highlighted by encircling it to show the effect of 
each filter step. 
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Based on the results obtained and the knowledge acquired, a new graphics interface for data 
acquisition was designed. This tracking application is developed using Qt [90] for user interface 
design and OpenCV [82] for image processing. As large quantities of data are expected to be 
collected from each of the magnetophoretic characterization experiences, more tailoring is added 
to the tracking process. 
5.2 Tracking tool description 
The new object detection and tracking software implementation is designed to be simple, 
and then some assumptions are made. The first assumption is that the user of the tracking 
software knows a priori the fluid flow speed at which the magnetophoretic experience has been 
made. This information is key for the well-functioning of it, because it is used to estimate the 
motion of magnetic aggregates. The second assumption is that the user knows or is able to 
indicate to the software a region of known physical size. This information is used to estimate the 
magnetophoretic velocity in terms of real physical quantities. 
In the new software implementation, in the first step the user can select and open the file 
containing the video with the recorded experience. In the next step the user must enter the fluid 
flow speed used to perform the experiment as shown in Figure 5-4. During the opening of the 
video file, the frame rate is automatically saved by OpenCV opening video function.  
 
Figure 5-4 Window to enter fluid flow speed used in the opened video. 
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The following step allows the spatial scaling of images. In the current software version it is 
assumed that pixels have a square shape, and then horizontal and vertical sizes are the same. 
Spatial calibration is used to calculate the conversion factor between pixel dimensions and 
physical real-world ones. In order to do so, the user has to define an area of known horizontal 
size; as shown in Figure 5-5. The vertical black lines shown in Figure 5-5 were designed with 
spatial calibration in mind; these lines are evenly spaced, separated by 1 mm between each other. 
Therefore they represent the length of the magnetophoretic chamber, i.e., 7 mm. These lines 
belong to a paper sheet that is placed below the microfluidic device. In Figure 5-5 a) is shown the 
message presented to the user to ask for draw a rectangle with known horizontal size. In Figure 
5-5 b) the rectangle has been drawn over the spatial calibration black vertical lines and the user is 
asked to enter the horizontal size of it (in mm); in this case 7 mm. In Figure 5-5 c), the user is 
shown with the resulting conversion factor, which in this case is 27 pixels/mm (or equivalently 
37 µm/pixel).By having this conversion factor is possible to calculate velocities and other 
quantities in physical units in the next steps.  
 
 
Figure 5-5 Spatial calibration. Selection of a region of known horizontal size that 
is used to calculate the equivalent size in pixels, in this case the result is 27 
pixels/mm. 
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The user is then prompted to select the tracking region, in this way it is possible to save 
computing resources; this step is shown in Figure 5-6. In Figure 5-6 a) the user is shown a 
message indicating that he has to select the tracking region. In Figure 5-6 b) the user is asked to 
confirm that the tracking region is correct. This step allows the user to change the tracking region 
if it has not been selected properly. Once the tracking region is selected, the video is loaded and 
the tracking process starts. 
 
Figure 5-6 Tracking region selection. The user can define the region in which 
the tracking is to be performed. 
 
5.2.1 Frame processing 
The flowchart of the preliminary tracking process is summarized in Figure 5-7. As 
indicated in Chapter 2, the first step is to detect objects in each frame. As mentioned in Chapter 3, 
the recorded videos have illumination problems.  
The video is accessed frame by frame in a loop that ends when no more frames are 
available. Frames are imported using the OpenCV query frame functionality. The frames are 
stored as an IplImage structure. It is possible to use a camera to feed a videostream instead of just 
opening a saved video file. 
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Figure 5-7 Simple flowchart of the preliminary tracking software. 
 
Due to the fact that magnetic microparticle aggregations have chain-like shapes, a Sobel 
filter is applied to detect vertical edges in the selected tracking region (Figure 5-8a) ). One the 
effects of using this filter is that horizontal lines are eliminated. In Figure 5-8a) is shown the 
result of using this filtering step on a region defined in the previous step that included the black 
horizontal drawn line used to better visualize the edges of the magnetophoretic chamber. This 
horizontal line is not present in Figure 5-8a), because the filtering process has eliminated it. In 
this way fewer false positive objects are detected. The resulting image includes a long diagonal 
line in the right-bottom corner, which corresponds to a black drawn line used to delimit the edges 
of the microfluidic chamber. It also includes a portion of the corresponding diagonal line 
delimiting the other part of the magnetophoretic chamber, which is seen in the left bottom corner. 
The chain like microparticle aggregation is the vertical line in the right-top corner in Figure 
5-8a). 
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Figure 5-8 Image processing prior to tracking. 
 
In order to remove noise, the function cvSmooth is used to perform a median filter (Figure 
5-8b)). The smooth process using the median filter depends on the selection of the appropriate 
filter window size. For the frames shown here the median filter window size selected is 3×3. In 
future evolutions of the tracking tool, the size of the window used for the median filter is to be 
adjustable. The window size affects the quality of the smoothing process. The use of the median 
filter for the smoothing process was due to the fact that has the ability to usually preserve edges 
better than other smoothing techniques. 
The resulting image is dilated in order to increase the size of the zone where aggregations 
are (Figure 5-8c)). As at this time the actual size of aggregations is not being determined, dilation 
can be safely used because the centroid of the dilated magnetic microparticle aggregations is 
conserved. As we are interested in calculating the magnetophoretic velocity, the centroid of the 
aggregation is used to estimate the magnetophoretic speed. The dilation process is done 3 times 
with a 3×3 structure element. 
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In the next step the resulting image is re-scaled to make the aggregations easier to identify 
(Figure 5-8d)). The re-scale process is simply the multiplication of each pixel in the image by 2 
(in our case). In this way, the contrast in the image is incremented by making the aggregations 
and other elements in the frame brighter than the background. One problem generated in this step 
is that the noise also gets and increased contrast. 
In order to eliminate noise generated in the precedent step, thresholding is applied. After 
some tests it was found that making 0 to every pixel value less than 50 produced the best result 
for the video sequences discussed here (Figure 5-8e)), in the sense of preserving microparticle 
aggregations while making other artifacts be part of the background. 
The process described here is repeated with each frame in the video to be processed. The 
final result includes the drawn diagonal lines used to mark the edges of the microfluidic chamber 
(bottom portion in Figure 5-8e)) and the microparticle aggregation (top portion in Figure 5-8e)). 
In the next step the object detection is performed by using the function cvFindContours that 
returns the number of retrieved contours and a pointer to the first one. The retrieved contours are 
processed by calculating their area; each contour that belongs to a window of permitted area 
values is saved in an array. This array contains the contours that are the moving object candidates 
for tracking. The Figure 5-8f) shows the possible moving objects detected in the first frame for 
the 2.6 mm/s movie used in Chapter 3. 
5.2.2 Motion estimation 
In the final step the movement of the magnetic microparticle aggregations is estimated by 
using the flow speed that the user has entered to define a search window in the sense of the flow. 
To do so a simple deterministic translational model is used, in which if In and In-1 are the 
horizontal positions of the object in the frames n and n - 1 respectively they are related by: 
In	=	In-1	+	δ         5-1 
where δ is the displacement that defines the position around which the search area is set in the 
next frame, and can be computed as: 
δ	=	Uolow	ScaleFR      5-2 
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where Uflow is the user-entered fluid flow speed, Scale is the calculated equivalence between 
distance and pixels, and FR is the automatically obtained frame rate of the video sequence.  
Another common displacement model is given by the Kalman filter method that uses the 
state space approach; it is intended to deal with noise and random perturbations that usually occur 
in real video data. This method is more accurate and robust than the translational one, but uses 
more computational power. The goal of this project is not to provide a way to estimate all 
possible particle movements and a simple deterministic translational model can be safely used 
due to the fact that microparticle aggregations are expected to follow fluid flow lines in its 
horizontal displacement. It is also supposed that only one object is moving between frames. The 
control of bolus injection goes beyond the boundaries of this thesis. 
If a particle is found inside the search window, the vertical position is verified to eliminate 
the possibility of noise being detected as a particle, or another particle being confused with the 
tracked one. The results obtained with this approach are shown in Figure 5-9 for the 2.6 mm/s 
video in which 2 particles are detected and the speeds are calculated. In this case the second 
particle is just noise, while the first particle is the main magnetic aggregation that is moving in 
this sequence. One thing to notice is the speed estimated by the software. The fluid flow is 
expected to be 2.6 mm/s, but the calculations based on tracking of the aggregations results in 3.3 
mm/s. On the other hand, the magnetophoretic speed estimated in this case is 0.7 mm/s, which is 
much less than the initially estimated one. One of the reasons for this could be the fact that the 
speed is being estimated by calculating the total vertical distance traveled during the entire 
tracking time. In this specific case, the aggregations are moving in several frames only due to the 
fluid flow, then after some frames the magnetic gradient is applied. Then the magnetophoretic 
velocity could be under-estimated in this case. The result of applying the tracking software to the 
movie in which the fluid flow is 5.2 mm/s is shown in Figure 5-10. 
Following up of the movement of magnetic aggregations by human eye was possible in the 
videos collected during experiences, but automatic tracking proven to be difficult as the 
aggregations were clear only at the lowest speeds. This preliminary tracking software 
development shows that the magnetophoretic chamber designed can be useful to characterize 
magnetic microentities intended for the use in MRN. Of course more work needs to be done in 
order to get a fully working testbench. One of the main limitations of the set-up is the low-speed 
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camera used (15 frames/s with a higher limit of 30 frames/s). A higher-speed higher-resolution 
camera should produce videos easier to track, implying that more data needs to be treated. 
 
Figure 5-9 Deflection pattern of aggregations in 2.6 mm/s movie. 
 
 
Figure 5-10 Deflection pattern of aggregations in 5.2 mm/s movie. 
 
Finally, as mentioned in [59], there are a lot of tracking tools available commercially and 
freeware, but often image data must satisfy conditions that are usually violated in experimental 
environments, which in turn provoke the tracking to fail. Next generation of the tracking software 
for measuring magnetophoretic attributes must include tools to allow the modification of 
obtained images (image preprocessing could be interactive) and trajectories. 
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5.2.3 Location accuracy  
In order to assess the accuracy of the tracking method proposed here for magnetophoretic 
experiences, simulated videos were generated in MATLAB with known trajectory data. 
The videos were generated assuming that the magnetic aggregations have a spheroid shape. 
The speeds in X range from 1 to 20 pixels/frame, and in Y a constant velocity of 2 pixels/frame is 
used. In order to investigate the effects of noise on the performance of the tracking software, new 
videos were generated starting from the basic initial one. The first source of noise is a spatial 
illumination variation; this variation is, by now, only in terms of columns in the generated 
images. Starting from these 2 videos, Gaussian white noise with known σ is added in order to 
generate image sequences with predefined signal to noise ratio (SNR). The SNR used in this 
project is defined by 
' = 10 log`

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
                                                   5-3 
with σgt2 and σn2 the varianzas of the image without noise and of the noise itself. Eq. 5-11 is used 
to compute the varianza strating from a known SNR. 
The SNR range was logarithmic with 10 steps starting with a value of 0.1 dB up to 39.8 dB. 
For the case of videos without spatial illumination noise, in all cases the maximum error in 
determining the centroid of the ellipsoid was 1 pixel in the x and y axis. However when the 
spatial illumination noise was added, only in the case of SNR bigger than 20 dB, the tracking 
software is capable of correctly determine the centroid of the simulated aggregation. 
These experiences indicate that with good quality video sequences, it is possible to obtain 
accurate data on the movement of magnetic aggregations in the magnetophoretic chamber. The 
spatial illumination variation can be attenuated by using the appropriate filter prior to the tracking 
process. 
The long term goal of these measurements it is to provide the data to populate a database 
containing main magnetic microcarrier characteristics. This database is expected to be accessed 
by the MRN core software to provide the medical team with suggestions about the better 
magnetic navigable entity to be used in a specific situation. 
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This data could also provide the means to estimate the outcome of the MRN treatment. For 
instance, in [91] a stochastic model is proposed to predict the behavior of a system of 
microrobots powered by bacteria. The stochastic model defines a series of macroscopic 
parameters that are determined by using movement experimental data. Then, if a similar model is 
defined for MRN treatments, the outcome of magnetocphoretic experiences could be used to 
estimate similar macroscopic parameters and then predict the targeting efficiency. 
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CHAPTER 6 GENERAL DISCUSSION 
 
This chapter includes a discussion on the methodology used and possible improvements at 
experimental and software levels. 
6.1 Experimental setup 
As usual in microfluidics, in the project it was assumed the non-slip boundary condition, 
which states that a fluid in contact with a stationary boundary has zero velocity. This implies that 
when particles settle they should stop moving and then should not contribute to the calculation of 
the magnetophoretic velocity, then if microparticles aggregations are moving, we are assuming 
that they have not settled yet. However, it is more likely that settled microparticles will roll due 
to the force exerted by the fluid, and this effect is difficult to compute. In order to avoid this 
effect, some solutions exist. One way to avoid settling effects is by changing the viscosity of the 
fluid in order to increase the settling time. If this solution is used, it is necessary to study the 
validity of Eq. 4-12, but in the case of chain-like aggregations. 
Usually the magnetic chain like aggregation shape is approximated by cylindrical or 
ellipsoid geometries [55, 76]. If the ellipsoid geometry and low particle Reynolds number for 
magnetic particle aggregation chain like are assumed, the drag force on it can be written in terms 
of a correction factor [92] for the drag force on an equivalent sphere 
Fd_agg	=	6fE	πμreU       6-1  
where fE is the Stokes correction coefficient and re is the radius of the equivalent sphere with the 
same volume as the ellipsoid. The correction coefficient fE depends on the aspect ratio E of a 
spheroid given by 
 E	=	 d	||d	┴        6-2  
with d|| the length of the semi-axis parallel and d┴ the length of the semi-axis perpendicular to the 
symmetry axis of the spheroid, in Figure 6-1 the semi-axis are schematically represented for a 
prolate ellipsoid case. The values for the coefficient fE in function of E can be found elsewhere 
[92]. 
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Figure 6-1 Prolate ellipsoid representing magnetic chain-like aggregation shape. 
 
As mentioned before, the Reynolds number for a moving particle (or aggregation) in a fluid 
flow is given by: 
Re-p	 = 	UDepν-1	 = 	2U;SUν-1	    6-3  
with Dep = 2rep the diameter of the equivalent sphere particle. Eq. 5-1 is only valid if Re-p « 1, 
then if we suppose that Dep is 300 µm and if the fluid has the kinematic viscosity of water            
(1 × 10-6 m2/s), the translational speed of the aggregation due to the applied magnetic force must 
be much less than 3 mm/s (which is the case in our experiences). If the kinematic viscosity is 
augmented, the maximum deflection speed of magnetic particle aggregation also increases. For 
example, if the kinematic viscosity of the fluid is designed to be the one of blood: 3.3 × 10-6 m2/s, 
the magnetic particle aggregation must reach a velocity much less than 11 mm/s, which is the 
case in our experiments. 
Again magnetic and drag forces balance, so the magnetically induced velocity on the 
aggregation is: 
 Umag_agg	=		Vf_agg(M∙∇)B
6fEπμre
      6-4  
67 
 
where Vf_agg is the volume of the ellipsoid shaped aggregation. Rearranging Eq. 5-4 we could 
estimate that 
 Umag_aggμ		2re2M∇B9fE         6-5  
is constant for a given aggregation in a given gradient, if the Reynolds number of the magnetic 
microparticle aggregation is low. Usually glycerol-water mixtures are used to get higher 
viscosities while keeping a density similar to water [93] (e.g., a mixture with 60% of pure water 
and 40% of glycerol is usually used to simulate blood viscosity).  
Neutrally buoyant microparticles can be used to estimate the coefficient of friction 
experienced by magnetic particles by comparing the navigation of both specimens without the 
influence of the magnetic force. Neutrally buoyant microparticles are expected to not sediment 
and follow the streamlines of fluid flow. This also can be used to better calibrate the fluid flow 
speed and to investigate the laminarity of the fluid flow in the magnetophoretic chamber. 
On the other hand, it is also possible to perform the experiences by placing the 
microfluidics device with fluid flow and gravity in parallel; in this case the effect of gravity must 
be included in the deflection equation. The aggregations and microparticles should never interact 
directly with the wall surfaces in this case. This solution is relatively simple but does not allow an 
easy study of the effect of the angle between chain like aggregations and magnetic field gradient 
in the magnetophoretic response. 
As mentioned in [10, 70] the microfluidics design can be improved to facilitate the 
repeatability of experiences. In the current design, if the magnetic force is turned on before the 
magnetic aggregations have reached the magnetophoretic chamber, the trajectory followed by 
them is too pronounced; this situation is represented in Figure 6-2 in which green aggregations 
have been propelled too early. 
It is also desirable that the new design has several outlets. The process of magnetic 
aggregation is complicated and depends on several factors as magnetic particle concentration, 
magnetic content in the microcarriers to mention some. It is expected that most of the magnetic 
microcarriers should aggregate, but some of them would remain unaggregated. The ratio of 
aggregated and unaggregated magnetic microcarriers directly influences the targeting effieciency. 
It is more likely that aggregated microparticles are going to respond as expected to the applied 
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magnetic gradient. With a multiple outlet magnetophoretic chamber it could be possible to 
estimate the fraction of aggregated magnetic particles for given experimental conditions. By 
knowing this ratio, it is possible to better estimate how much of the therapeutic agent could reach 
the tumor in similar conditions and the treatment planning could be done accordingly. 
 
Figure 6-2 Current chamber design problem. Aggregations represented in blue 
are subjected to the magnetic gradient at the right time. In green is represented 
the situation when the magnetic gradient is turned on too early. 
 
Due to the size of the magnetic microparticles used in this experience, Brownian motion 
induced by thermal energy can be safely ignored. In effect, the dimensionless Péclet number 
measures the relative importance of diffusive transport (due to Brownian motion) versus 
convective transport 
Pe		UolowDhD          6-6  
with the diffusion coefficient D given by Stokes-Einstein's expression: 
D	 kBT6πμr          6-7  
where kB is the Boltzmann’s constant and T is the absolute temperature. If Pe ≫	1, diffusion is 
considered absent and microparticles follow flow lines [94]. In our case supposing a temperature 
of 20 °C, and using the particles radius of 40 µm and the minimum flow speed of 2.6 mm/s, the 
69 
 
Péclet number results in 9.8 × 107 as worst case, which indicates that Brownian motion is 
negligible compared with convective transport and magnetic microparticles can be considered 
following fluid flow streamlines. 
In [95] it is mentioned that the distortion in fluid flow caused by the movement of a 
microparticle can induce a drag force into other ones, and so affecting their trajectories. This 
effect has been neglected but maybe it could be important to asses it in future developments. 
As it has been mentioned before, one of the main problems of the current setup is the fact 
that the effect of gravity is being neglected. The use of higher viscosity fluids is discussed as a 
possible solution. A different disposition of the setup such the movement of the magnetic 
aggregations could be parallel to the gravity is also discussed to avoid this problem; however the 
influence of chain like aggregation angle with respect to the magnetic gradient is more difficult to 
assess when using this disposition.  
6.2 Data acquisition software 
The tracking software presented here can be used to estimate the response of the magnetic 
microcarriers when used in conjunction with the magnetophoretic chamber described. There is 
room for improvement in the pre-filtering process and in the tracking process. The motion 
estimation model used for tracking magnetic microcarrier aggregations is very simple, but 
performs its task of allowing the estimation of the deflection pattern. The use of contextual 
information allows a better performance than the use of the general purpose tracking application 
used initially. 
The initial established problem for this project was to design a device capable of allowing 
the collection of data on the magnetic response of therapeutic and/or diagnostic microcarriers 
when used in MRN. The first step to propose a solution to an engineering problem is to 
understand the nature of it. When the nature of the problem is clear, it is possible to decide if the 
use of computer science tools is useful to its solution or not. The screening work presented up to 
this point has allowed us to better understand the implications of the measurement of 
magnetophoretic attributes of therapeutic and/or diagnostic microcarriers.  
The MRN system is expected to be composed basically by three main data source modules, 
plus a core software module [48]. The first data source is the physiological data, including blood 
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flows, pre-recorded images of the vasculature surrounding the target zone, etc. The second source 
of data is the system data related mainly to propulsion capacities of the system. Finally, the third 
source of data is the magnetic microcarriers database. The MRN system is expected to operate 
accessing this data sources to provide the medical team with all the resources needed to perform a 
MRN intervention. 
This project can provide insights on the way in which the magnetic therapeutic/diagnostic 
microcarriers database can be designed and populated. Next generation of the data acquisition 
software developed for this thesis must include a step to retrieve information on magnetic 
navigable entities as: microcarrier identification, microcarrier magnetic content, microcarrier 
therapeutic agent identification, microcarrier therapeutic content and microcarrier size among 
others. After performing magnetophoretic experiences, the data acquisition software should 
generate data on magnetophoretic velocity, and the ratio of aggregated and unaggregated 
magnetic microparticles, as a very minimum. All this information is to be saved in a database and 
could be used to feed a theoretical model to determine the best route to reach the target, estimate 
the MRN intervention expected efficiency and help the medical team in selecting the appropriate 
therapeutic entity for a given patient. The present work can be used as the base for building such 
a complete platform to characterize any potential therapeutic and/or diagnostic microentity.  
 
 
 
  
 
71 
CHAPTER 7 CONCLUSION 
 
The aim of this project was to design and test a device to allow the characterization of the 
deflection patterns of magnetic microentities intended for diagnostic and/or therapeutic targeted 
interventions. A microfluidic chamber was designed and preliminary results were presented. The 
magnetophoretic chamber designed allowed the observation of the movement of chain-like 
magnetic microparticle aggregations of around 200 µm in size. 
In Chapter 2 the literature review is presented. A basic theoretical background on 
magnetophoresis and the application of magnetophoresis in magnetic manipulation is initially 
presented. Next the MRN technique as a novel cancer treatment alternative is presented, putting 
emphasis on the fact that magnetic microcarriers trajectory experimental studies, to our best 
knowledge, have not been performed up to now. Finally the common techniques used for 
tracking particles while moving in a flow are presented. 
In Chapter 3 the methodology used in this research project is outlined. The microfluidics 
design is presented with some details; the simulation framework is explained jointly with the 
expected results from magnetophoretic experiences based on its results. Experimental results that 
are part of a conference paper are summarized. Finally the reasons for use OpenCV and Qt are 
explained. 
A preliminary framework for tracking and data acquisition of magnetophoretic attributes is 
presented in Chapter 4. The initial exploration of the OpenCV blobtrack application, used in 
other project in the laboratory, is the main subject of this chapter. The results were promissory, 
even though there are problems with this tracking tool.  
Taking into account the results obtained with the blobtrack application, a simple tracking 
software based in a translational model is proposed and applied to videos used in [10]. This 
simple tracking program shows better performance when compared with the OpenCV blobtrack 
sample application and is presented in Chapter 5. 
In Chapter 6 the possible improvements at the experimental setup level are discussed. Some 
of the design decisions presented in Chapter 3 are reviewed, mainly regarding the positioning of 
the input inlet and the use of several outputs. It is also discussed the use of higher viscosity 
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liquids as transport fluid in order to avoid sedimentation. The validity of the assumption that 
using magnetphoretic velocity results in fluid flow of known viscosity can be used to estimate 
magnetophoretic velocity in blood is investigated. At the software level,  this chapter puts the 
developed software in perspective with respect to the whole MRN system. 
The work of this project could be extended in several directions: 
• Repeating the experiences presented in [10] by using higher viscosity fluid and 
lower fluid flow speeds. By using neutrally buoyant particles it could be possible to 
evaluate the accuracy of fluid flow speeds and laminarity of the flow. 
• Performing deflection experiences using the upgraded MRN platform [96] to 
generate propulsion forces in different angles with respect to the chain-like aggregations. 
• Performing experiences with a magnetophoretic chamber having several outputs in 
order to estimate aggregation size distributions. 
• Improving the tracking tool to detect individual particles. 
This work is inserted in the MR Sub project, and so, the broader goal of it is to provide the 
basis for future developments allowing the design and implementation of a magnetic navigable 
microentities database. The use of the magnetophoretic chamber design and the development of 
improvements in the data acquisition software can provide a way to characterize any potential 
therapeutic microcarrier. We expect this work will be useful to open new ways for future 
investigations of magnetic response of therapeutic/diagnosis microagents in order to better plan 
future MRN interventions.   
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APPENDIX 1– Rod model for chain-like magnetic aggregations 
One of the ways in which chain-like magnetic aggregations is approximated is by using a 
rod like representation.  
 
In the figure shown at the side the chain-like magnetic aggregation of n 
equal size particles is represented. Due to the fact that we know that all 
particles have the same size, we get: 
ℎ  B                                                        Ann1-1 
The volume of a cylinder (a rod) is: 
  	9;aℎ                                                    Ann1-2 
with r = d/2. Then the volume of the chain-like aggregation in terms of the 
diameter of their constituent particles is: 
  	 $? 9B@                                                    Ann1-3 
A sphere with an equivalent volume is 
  	 ?@9;S@                                                  Ann1-4 
and req = deq/2 we have that  
  	 `9BS@                                                  Ann1-5 
By equalizing Eq. Ann1-3 and Eq. Ann1-5, the diameter of the equivalent sphere is 
obtained: 
BS 	 @a
 	B                                             Ann1-6 
In the simulation case, n = 280 and d = 41.13 × 10-6 m with which we obtain an equivalent 
diameter of deq = 308.017× 10-6 m. 
